This is a Validated Antibody Database (VAD) review about mouse Mrc1, based on 236 published articles (read how Labome selects the articles), using Mrc1 antibody in all methods. It is aimed to help Labome visitors find the most suited Mrc1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Mrc1 synonym: AW259686; CD206; MR

Knockout validation
Abcam
domestic rabbit polyclonal
  • western blot knockout validation; mouse; loading ...; fig s1d
Abcam Mrc1 antibody (Abcam, ab64693) was used in western blot knockout validation on mouse samples (fig s1d). Proc Natl Acad Sci U S A (2022) ncbi
BioLegend
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:100; loading ...; fig 1c
BioLegend Mrc1 antibody (Biolegend, C068C2) was used in flow cytometry on mouse samples at 1:100 (fig 1c). J Hematol Oncol (2022) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:25; loading ...
BioLegend Mrc1 antibody (Biolegend, 141717) was used in flow cytometry on mouse samples at 1:25. Nat Commun (2022) ncbi
rat monoclonal (C068C2)
  • immunohistochemistry - frozen section; mouse; 5 ug/ml; loading ...; fig 2a
BioLegend Mrc1 antibody (BioLegend, 141712) was used in immunohistochemistry - frozen section on mouse samples at 5 ug/ml (fig 2a). Cell Rep (2022) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 6a
BioLegend Mrc1 antibody (BioLegend, 141,705) was used in flow cytometry on mouse samples (fig 6a). Arthritis Res Ther (2022) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig 1c). Int J Immunopathol Pharmacol (2022) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 4c, s2b
BioLegend Mrc1 antibody (Biolegend, C068C2) was used in flow cytometry on mouse samples (fig 4c, s2b). Oncoimmunology (2022) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 4f
BioLegend Mrc1 antibody (Biolegend, 141707) was used in flow cytometry on mouse samples (fig 4f). Oncoimmunology (2022) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; fig 2f
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig 2f). Proc Natl Acad Sci U S A (2022) ncbi
rat monoclonal (C068C2)
  • immunohistochemistry; mouse; 1:500; loading ...; fig s5d
BioLegend Mrc1 antibody (BioLegend, 141712) was used in immunohistochemistry on mouse samples at 1:500 (fig s5d). Adv Sci (Weinh) (2022) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:20; fig e8a, e8f
BioLegend Mrc1 antibody (BioLegend, 141733) was used in flow cytometry on mouse samples at 1:20 (fig e8a, e8f). Nat Med (2022) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig s3f
BioLegend Mrc1 antibody (Biolegend, C068C2) was used in flow cytometry on mouse samples (fig s3f). Front Immunol (2021) ncbi
rat monoclonal (C068C2)
  • immunohistochemistry; mouse; loading ...; fig 3a
BioLegend Mrc1 antibody (Biolegend, 141707) was used in immunohistochemistry on mouse samples (fig 3a). Nat Commun (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; fig 3b
BioLegend Mrc1 antibody (BioLegend, 141708) was used in flow cytometry on mouse samples (fig 3b). Int J Mol Sci (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:100; loading ...; fig s3b
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples at 1:100 (fig s3b). Nat Commun (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...
BioLegend Mrc1 antibody (Biolegend, C068C2) was used in flow cytometry on mouse samples . PLoS Pathog (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 5b, 5h
BioLegend Mrc1 antibody (Biolegend, 141734) was used in flow cytometry on mouse samples (fig 5b, 5h). J Immunother Cancer (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 2c
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig 2c). JCI Insight (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 5g
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig 5g). Front Immunol (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:200; loading ...
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples at 1:200. Cancer Res (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 3d
BioLegend Mrc1 antibody (BioLegend, 141703) was used in flow cytometry on mouse samples (fig 3d). Cell Death Discov (2021) ncbi
rat monoclonal (C068C2)
  • immunohistochemistry; mouse; loading ...; fig 2b
BioLegend Mrc1 antibody (Biolegend, 141706) was used in immunohistochemistry on mouse samples (fig 2b). Sci Rep (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:100; loading ...; fig 2a
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples at 1:100 (fig 2a). Sci Rep (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:25; loading ...; fig 8a
BioLegend Mrc1 antibody (Biolegend, 141707) was used in flow cytometry on mouse samples at 1:25 (fig 8a). Cell Death Dis (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:130; loading ...; fig 3a
BioLegend Mrc1 antibody (Biolegend, 141717) was used in flow cytometry on mouse samples at 1:130 (fig 3a). MBio (2021) ncbi
rat monoclonal (C068C2)
  • immunocytochemistry; mouse; loading ...; fig 4a
  • immunohistochemistry; mouse; loading ...; fig 6a
BioLegend Mrc1 antibody (BioLegend, 141-711) was used in immunocytochemistry on mouse samples (fig 4a) and in immunohistochemistry on mouse samples (fig 6a). Adv Sci (Weinh) (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 3e
BioLegend Mrc1 antibody (BioLegend, 141705) was used in flow cytometry on mouse samples (fig 3e). Cell Death Dis (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 3i
BioLegend Mrc1 antibody (Biolegend, 141705) was used in flow cytometry on mouse samples (fig 3i). Mol Cancer (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; fig 1d
BioLegend Mrc1 antibody (BioLegend, 141705) was used in flow cytometry on mouse samples (fig 1d). Physiol Rep (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:200; loading ...
BioLegend Mrc1 antibody (Biolegend, C068C2) was used in flow cytometry on mouse samples at 1:200. Nat Commun (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:200
BioLegend Mrc1 antibody (Biolegend, 141703) was used in flow cytometry on mouse samples at 1:200. elife (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:200
BioLegend Mrc1 antibody (Biolegend, 141703) was used in flow cytometry on mouse samples at 1:200. elife (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig ev2-7
BioLegend Mrc1 antibody (BioLegend, 141719) was used in flow cytometry on mouse samples (fig ev2-7). EMBO Mol Med (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; human; loading ...
BioLegend Mrc1 antibody (Biolegend, 141717) was used in flow cytometry on human samples . J Immunother Cancer (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig s3d
BioLegend Mrc1 antibody (Biolegend, 141723) was used in flow cytometry on mouse samples (fig s3d). Cell (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 4e
BioLegend Mrc1 antibody (Biolegend, 141719) was used in flow cytometry on mouse samples (fig 4e). J Exp Med (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:50; loading ...; fig 6b
BioLegend Mrc1 antibody (Bioloegend, C068C2) was used in flow cytometry on mouse samples at 1:50 (fig 6b). Front Physiol (2021) ncbi
rat monoclonal (C068C2)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 3e
BioLegend Mrc1 antibody (BioLegend, 141701) was used in immunohistochemistry on mouse samples at 1:500 (fig 3e). NPJ Regen Med (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend Mrc1 antibody (BioLegend, 141712) was used in flow cytometry on mouse samples (fig 2a). Antioxidants (Basel) (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples . J Reprod Immunol (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig s5a
BioLegend Mrc1 antibody (Biolegend, 141712) was used in flow cytometry on mouse samples (fig s5a). JCI Insight (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 11a
BioLegend Mrc1 antibody (BioLegend, 141711) was used in flow cytometry on mouse samples (fig 11a). Cell Mol Gastroenterol Hepatol (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig s26
BioLegend Mrc1 antibody (BioLegend, 141712) was used in flow cytometry on mouse samples (fig s26). Nat Commun (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:100; loading ...; fig s4f
BioLegend Mrc1 antibody (Biolegend, C068C2) was used in flow cytometry on mouse samples at 1:100 (fig s4f). Proc Natl Acad Sci U S A (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 5a
BioLegend Mrc1 antibody (Biolegend, 141706) was used in flow cytometry on mouse samples (fig 5a). Front Cell Dev Biol (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 3a-c
BioLegend Mrc1 antibody (BioLegend, 141734) was used in flow cytometry on mouse samples (fig 3a-c). Sci Adv (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 6d
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig 6d). Aging (Albany NY) (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 5d
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig 5d). Front Immunol (2020) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:50; fig 7
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples at 1:50 (fig 7). Adv Sci (Weinh) (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 4b
BioLegend Mrc1 antibody (BioLegend, 141708) was used in flow cytometry on mouse samples (fig 4b). PLoS ONE (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 7g
BioLegend Mrc1 antibody (BioLegend, 141703) was used in flow cytometry on mouse samples (fig 7g). Nat Commun (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:100; loading ...; fig s4a
  • flow cytometry; human; 1:100; loading ...; fig s8a
BioLegend Mrc1 antibody (BioLegend, 141713) was used in flow cytometry on mouse samples at 1:100 (fig s4a) and in flow cytometry on human samples at 1:100 (fig s8a). Nat Commun (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:400; loading ...; fig e10e
BioLegend Mrc1 antibody (Biolegend, C068C2) was used in flow cytometry on mouse samples at 1:400 (fig e10e). Nat Neurosci (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig 3a). Int J Mol Sci (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:100; fig 4a
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples at 1:100 (fig 4a). Am J Physiol Endocrinol Metab (2020) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:100; loading ...; fig 5f
BioLegend Mrc1 antibody (BioLegend, 141734) was used in flow cytometry on mouse samples at 1:100 (fig 5f). PLoS Biol (2020) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 4f, s3g
BioLegend Mrc1 antibody (Biolegend, 141706) was used in flow cytometry on mouse samples (fig 4f, s3g). Gastroenterology (2021) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...
BioLegend Mrc1 antibody (Biolegend, C068C2) was used in flow cytometry on mouse samples . Front Immunol (2020) ncbi
rat monoclonal (C068C2)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 2i
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 2i). Aging Cell (2020) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:400; loading ...; fig 6l
BioLegend Mrc1 antibody (Biolegend, 141715) was used in flow cytometry on mouse samples at 1:400 (fig 6l). Cell (2020) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 2d, 2e
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig 2d, 2e). Nat Commun (2020) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples . Sci Adv (2020) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig s9
BioLegend Mrc1 antibody (BioLegend, 141733) was used in flow cytometry on mouse samples (fig s9). Nat Chem Biol (2020) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig s3a, s3b, s3c, s4a
BioLegend Mrc1 antibody (BioLegend, 141706) was used in flow cytometry on mouse samples (fig s3a, s3b, s3c, s4a). Cancers (Basel) (2020) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 5c
BioLegend Mrc1 antibody (Biolegend, 141704) was used in flow cytometry on mouse samples (fig 5c). Aging (Albany NY) (2020) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:200; loading ...; fig 3b
BioLegend Mrc1 antibody (BioLegend, 141734) was used in flow cytometry on mouse samples at 1:200 (fig 3b). Nat Commun (2020) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:100; loading ...; fig 3s1
BioLegend Mrc1 antibody (Biolegend, 141712) was used in flow cytometry on mouse samples at 1:100 (fig 3s1). elife (2019) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:200; loading ...; fig 4e, 8h
BioLegend Mrc1 antibody (Biolegend, 141732) was used in flow cytometry on mouse samples at 1:200 (fig 4e, 8h). Nat Commun (2019) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:100; fig s7l
BioLegend Mrc1 antibody (Biolegend, 141732) was used in flow cytometry on mouse samples at 1:100 (fig s7l). Cancer Cell (2019) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig s1f
BioLegend Mrc1 antibody (Biolegend, 141705) was used in flow cytometry on mouse samples (fig s1f). Cell (2019) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:200; loading ...
BioLegend Mrc1 antibody (BioLegend, 141708) was used in flow cytometry on mouse samples at 1:200. elife (2019) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig s2e
BioLegend Mrc1 antibody (Biolegend, 141712) was used in flow cytometry on mouse samples (fig s2e). Science (2019) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend Mrc1 antibody (BioLegend, 141709) was used in flow cytometry on mouse samples (fig 1a). Immunity (2019) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig s4a
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig s4a). Proc Natl Acad Sci U S A (2019) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 5b
BioLegend Mrc1 antibody (Biolegend, C068C2) was used in flow cytometry on mouse samples (fig 5b). Nat Immunol (2019) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:100; loading ...; fig 9g
BioLegend Mrc1 antibody (BioLegend, 141729) was used in flow cytometry on mouse samples at 1:100 (fig 9g). J Immunol (2019) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:100; loading ...; fig 2c
BioLegend Mrc1 antibody (Biolegend, 141720) was used in flow cytometry on mouse samples at 1:100 (fig 2c). Neurochem Int (2019) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig s2
BioLegend Mrc1 antibody (Biolegend, C068C2) was used in flow cytometry on mouse samples (fig s2). Proc Natl Acad Sci U S A (2019) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig s8b
BioLegend Mrc1 antibody (eBioscience, C068C2) was used in flow cytometry on mouse samples (fig s8b). JCI Insight (2018) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 4
BioLegend Mrc1 antibody (Biolegend, C068C2) was used in flow cytometry on mouse samples (fig 4). Front Immunol (2018) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 2b
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig 2b). Front Immunol (2018) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; fig 2e
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig 2e). J Immunol (2018) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 1e
BioLegend Mrc1 antibody (Biolegend, 141706) was used in flow cytometry on mouse samples (fig 1e). Cancer Res (2018) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig 4a). Int J Obes (Lond) (2018) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 3g
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig 3g). Oncogene (2018) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig s1b
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig s1b). Cell Metab (2018) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig s1a
BioLegend Mrc1 antibody (Biolegend, C068C2) was used in flow cytometry on mouse samples (fig s1a). Proc Natl Acad Sci U S A (2018) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:100; loading ...; fig 4a
BioLegend Mrc1 antibody (Biolegend, C068C2) was used in flow cytometry on mouse samples at 1:100 (fig 4a). Front Immunol (2018) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 3d
BioLegend Mrc1 antibody (bioLegend, C068C2) was used in flow cytometry on mouse samples (fig 3d). J Exp Med (2018) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; fig 5b
In order to study the involvement of RANKL in decidual M2 macrophage polarization, BioLegend Mrc1 antibody (Biolegend, 141704) was used in flow cytometry on mouse samples (fig 5b). Cell Death Dis (2017) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:200; fig s6g
BioLegend Mrc1 antibody (Biolegend, 141703) was used in flow cytometry on mouse samples at 1:200 (fig s6g). Nat Cell Biol (2017) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...
In order to investigate the role of type I interferons in diet-induced obesity and insulin resistance, BioLegend Mrc1 antibody (Biolegend, C068C2) was used in flow cytometry on mouse samples . Diabetologia (2017) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 4c
In order to study the role of interleukin-4 and -13 in tissue repair and remodeling, BioLegend Mrc1 antibody (Biolegend, C068C2) was used in flow cytometry on mouse samples (fig 4c). Science (2017) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 1d
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig 1d). J Exp Med (2017) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 5c
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig 5c). J Exp Med (2017) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 4f
BioLegend Mrc1 antibody (Biolegend, C068C2) was used in flow cytometry on mouse samples (fig 4f). Nat Med (2017) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 2j
In order to clarify the roles of SIRT1 in adipose tissues, BioLegend Mrc1 antibody (Biolegend, C068C2) was used in flow cytometry on mouse samples (fig 2j). EMBO Rep (2017) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig s2a
BioLegend Mrc1 antibody (Biolegend, C068C2) was used in flow cytometry on mouse samples (fig s2a). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (C068C2)
In order to test if TRAIL/TRAIL-R signaling in cancer cells alters the immune microenvironment, BioLegend Mrc1 antibody (BioLegend, 141703) was used . Mol Cell (2017) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; fig 4j
In order to determine the contribution of B cell to obesity-induced insulin resistance, BioLegend Mrc1 antibody (BioLegend, 141706) was used in flow cytometry on mouse samples (fig 4j). J Clin Invest (2017) ncbi
rat monoclonal (C068C2)
In order to analyze rapid tumor volume and spatial information on tumor-associated macrophage infiltration at the cellular level, BioLegend Mrc1 antibody (BioLegend, 141704) was used . Nat Commun (2017) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:200; loading ...; fig 2s
BioLegend Mrc1 antibody (BioLegend, 141719) was used in flow cytometry on mouse samples at 1:200 (fig 2s). J Neurosci (2017) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 4a
In order to discover that SIRPalpha is highly expressed in human renal cell carcinoma and melanoma, BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig 4a). JCI Insight (2017) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 2d
BioLegend Mrc1 antibody (BioLegend, 141708) was used in flow cytometry on mouse samples (fig 2d). Sci Rep (2017) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 2c
In order to investigate temporal changes of the CD11b+ cell populations in the brain and protein expression of the immunomodulatory factor galectin-3 in neonatal hypoxia-ischemia brain tissue, BioLegend Mrc1 antibody (BioLegend, 141708) was used in flow cytometry on mouse samples (fig 2c). Front Cell Neurosci (2016) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 1d
In order to show that the MEK1/2 pathway is a key regulator of macrophage reparative properties, BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig 1d). J Immunol (2017) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 2b
In order to study the ability of lymphocyte-derived microparticles to modulate the gene expression pattern of angiogenesis-related factors in macrophages, BioLegend Mrc1 antibody (Biolegend, C068C2) was used in flow cytometry on mouse samples (fig 2b). Sci Rep (2016) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig s5d
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig s5d). Proc Natl Acad Sci U S A (2016) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 2
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig 2). Oncotarget (2016) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 6
In order to report that metformin inhibits advanced glycation end product-induced inflammatory response through AMPK activation and RAGE/NFkappaB pathway suppression, BioLegend Mrc1 antibody (BioLegend, 141704) was used in flow cytometry on mouse samples (fig 6). J Diabetes Res (2016) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; fig 4
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2016) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 5k
In order to study how IL-17 and IFN-gamma control Staphylococcus aureus infection, BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig 5k). Am J Pathol (2016) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; fig 3
BioLegend Mrc1 antibody (Biolegend, 141710) was used in flow cytometry on mouse samples (fig 3). Nat Commun (2016) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; fig s6a
In order to find a role for RelA in regulating oncogene-induced senescence, BioLegend Mrc1 antibody (biolegend, C068C2) was used in flow cytometry on mouse samples (fig s6a). J Clin Invest (2016) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; fig 2
BioLegend Mrc1 antibody (BioLegend, 141705) was used in flow cytometry on mouse samples (fig 2). Am J Transl Res (2016) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 3f
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig 3f). Oncotarget (2016) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:50; fig 1
BioLegend Mrc1 antibody (BioLegend, 141709) was used in flow cytometry on mouse samples at 1:50 (fig 1). J Clin Invest (2016) ncbi
rat monoclonal (C068C2)
BioLegend Mrc1 antibody (Biolegend, 141703) was used . Nat Commun (2016) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...; fig 2c
In order to test if administration of exogenous IL-19 reduces progression of preformed atherosclerotic plaque, BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig 2c). Am J Pathol (2016) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; fig 2e
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig 2e). Gastroenterology (2016) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; fig 2
BioLegend Mrc1 antibody (Biolegend, 141706) was used in flow cytometry on mouse samples (fig 2). PLoS ONE (2016) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:40; fig 1
In order to characterize macrophage polarization with fatty acid oxidation, BioLegend Mrc1 antibody (Biolegend, 141705) was used in flow cytometry on mouse samples at 1:40 (fig 1). Nat Immunol (2016) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; fig 3
BioLegend Mrc1 antibody (BioLegend, 141711) was used in flow cytometry on mouse samples (fig 3). Int J Mol Med (2016) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; fig s6
BioLegend Mrc1 antibody (Biolegend, 141706) was used in flow cytometry on mouse samples (fig s6). Sci Rep (2016) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; loading ...
In order to elucidate the role of miR-34a in efferocytosis, BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples . J Immunol (2016) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; fig s3
In order to analyze the promotion of the development of pancreatic neoplasia by IL35-producing B cells, BioLegend Mrc1 antibody (Biolegend, C068C2) was used in flow cytometry on mouse samples (fig s3). Cancer Discov (2016) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; fig 4
In order to report angiopoietin-2 as a target in both naive and bevacizumab-treated glioblastoma, BioLegend Mrc1 antibody (Biolegend, C068C2) was used in flow cytometry on mouse samples (fig 4). EMBO Mol Med (2016) ncbi
rat monoclonal (C068C2)
BioLegend Mrc1 antibody (BioLegend, 141707) was used . Oncogene (2016) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; fig 4
BioLegend Mrc1 antibody (Biolegend, 141703) was used in flow cytometry on mouse samples (fig 4). Biomed Res Int (2015) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse
BioLegend Mrc1 antibody (BioLegend, 141704) was used in flow cytometry on mouse samples . Cytometry A (2015) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; fig 1
In order to demonstrate that VEGF-B promotes cancer metastasis through tumor microvasculature remodeling, BioLegend Mrc1 antibody (BioLegend, 141709) was used in flow cytometry on mouse samples (fig 1). Proc Natl Acad Sci U S A (2015) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; 1:100; fig 3
BioLegend Mrc1 antibody (Biolegend, 141710) was used in flow cytometry on mouse samples at 1:100 (fig 3). Nat Commun (2015) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; fig 2
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig 2). J Immunol (2015) ncbi
rat monoclonal (C068C2)
  • immunohistochemistry - paraffin section; mouse; fig 1
In order to study the contribution of SEMA4D-PLXNB1 interactions to immune-cell trafficking in the tumor microenvironment, BioLegend Mrc1 antibody (BioLegend, CO68C2) was used in immunohistochemistry - paraffin section on mouse samples (fig 1). Cancer Immunol Res (2015) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; fig 3
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig 3). Immunology (2015) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse
BioLegend Mrc1 antibody (Biolegend, C068C2) was used in flow cytometry on mouse samples . Diabetes (2015) ncbi
rat monoclonal (C068C2)
  • flow cytometry; mouse; fig 3
BioLegend Mrc1 antibody (BioLegend, C068C2) was used in flow cytometry on mouse samples (fig 3). Glia (2015) ncbi
rat monoclonal (C068C2)
BioLegend Mrc1 antibody (BioLegend, 141705) was used . J Neurosci (2014) ncbi
Abcam
domestic rabbit polyclonal
  • immunocytochemistry; rat; 1:200; loading ...; fig 4a
Abcam Mrc1 antibody (Abcam, ab64693) was used in immunocytochemistry on rat samples at 1:200 (fig 4a). Front Cardiovasc Med (2022) ncbi
domestic rabbit polyclonal
  • flow cytometry; mouse; loading ...; fig 5c
  • immunohistochemistry; mouse; loading ...; fig 4a
Abcam Mrc1 antibody (Abcam, ab64693) was used in flow cytometry on mouse samples (fig 5c) and in immunohistochemistry on mouse samples (fig 4a). J Immunol Res (2022) ncbi
domestic rabbit polyclonal
  • western blot knockout validation; mouse; loading ...; fig s1d
Abcam Mrc1 antibody (Abcam, ab64693) was used in western blot knockout validation on mouse samples (fig s1d). Proc Natl Acad Sci U S A (2022) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig 4a
Abcam Mrc1 antibody (Abcam, ab64693) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 4a). EBioMedicine (2022) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:250; loading ...; fig s19a
Abcam Mrc1 antibody (Abcam, ab64693) was used in immunohistochemistry - paraffin section on mouse samples at 1:250 (fig s19a). Nat Commun (2022) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 7d
  • western blot; mouse; loading ...; fig 7a
Abcam Mrc1 antibody (Abcam, ab64693) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 7d) and in western blot on mouse samples (fig 7a). Front Pharmacol (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; human; 1:100; loading ...; fig 7b
Abcam Mrc1 antibody (Abcam, ab64693) was used in immunohistochemistry on human samples at 1:100 (fig 7b). Eur Respir J (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:100; loading ...; fig 4a
Abcam Mrc1 antibody (Abcam, ab64693) was used in immunohistochemistry on mouse samples at 1:100 (fig 4a). Cancers (Basel) (2021) ncbi
domestic rabbit monoclonal (EPR6828(B))
  • western blot; human; loading ...; fig 7d
Abcam Mrc1 antibody (Abcam, ab125028) was used in western blot on human samples (fig 7d). Cell Death Dis (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 2d
Abcam Mrc1 antibody (abcam, ab64693) was used in western blot on mouse samples (fig 2d). J Cell Mol Med (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:1000; loading ...; fig 3m
Abcam Mrc1 antibody (Abcam, ab64693) was used in immunohistochemistry on mouse samples at 1:1000 (fig 3m). Kidney Int Rep (2021) ncbi
domestic rabbit polyclonal
  • western blot; rat; loading ...; fig 8a
Abcam Mrc1 antibody (Abcam, ab64693) was used in western blot on rat samples (fig 8a). J Inflamm Res (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 2i
Abcam Mrc1 antibody (Abcam, ab64693) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 2i). Mol Metab (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 5d
Abcam Mrc1 antibody (Abcam, ab64693) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 5d). Int J Mol Sci (2021) ncbi
domestic rabbit monoclonal (EPR6828(B))
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 5c
Abcam Mrc1 antibody (Abcam, ab195192) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 5c). BMC Musculoskelet Disord (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:300; loading ...; fig 1c
Abcam Mrc1 antibody (Abcam, ab64693) was used in immunohistochemistry on mouse samples at 1:300 (fig 1c). Int J Mol Sci (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig s6e
Abcam Mrc1 antibody (Abcam, ab64693) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s6e). Nat Commun (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:100; loading ...; fig 4a
Abcam Mrc1 antibody (Abcam, ab64693) was used in immunohistochemistry on mouse samples at 1:100 (fig 4a). Adv Sci (Weinh) (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 6e
Abcam Mrc1 antibody (Abcam, ab64693) was used in western blot on mouse samples at 1:1000 (fig 6e). Aging (Albany NY) (2021) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; loading ...; fig 2g
Abcam Mrc1 antibody (Abcam, ab64693) was used in immunocytochemistry on human samples (fig 2g). Aging (Albany NY) (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig 6b
Abcam Mrc1 antibody (Abcam, ab64693) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 6b). Cancers (Basel) (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig st2
Abcam Mrc1 antibody (Abcam, AB64693) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig st2). Int J Mol Sci (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 6e
Abcam Mrc1 antibody (Abcam, ab64693) was used in immunohistochemistry - paraffin section on mouse samples (fig 6e). Sci Transl Med (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig 6g
Abcam Mrc1 antibody (Abcam, ab64693) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 6g). Cancer Cell (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:100-1:200; loading ...
Abcam Mrc1 antibody (Abcam, ab64693) was used in immunohistochemistry on mouse samples at 1:100-1:200. Acta Neuropathol (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; rat; 1:200; loading ...; fig 7i
Abcam Mrc1 antibody (Abcam, ab64693) was used in immunohistochemistry - paraffin section on rat samples at 1:200 (fig 7i). Cell Death Dis (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; loading ...; fig 5c
Abcam Mrc1 antibody (Abcam, ab64693) was used in immunohistochemistry on mouse samples (fig 5c). Theranostics (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; human; loading ...; fig 1b
  • western blot; human; loading ...; fig 3c
Abcam Mrc1 antibody (Abcam, ab64693) was used in immunohistochemistry on human samples (fig 1b) and in western blot on human samples (fig 3c). Redox Biol (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; loading ...; fig 1e
Abcam Mrc1 antibody (Abcam, ab64693) was used in immunohistochemistry - paraffin section on human samples (fig 1e). Cell (2019) ncbi
mouse monoclonal (15-2)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 2a
Abcam Mrc1 antibody (abcam, ab117644) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2a). Brain Pathol (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:300; loading ...; fig 1c
Abcam Mrc1 antibody (Abcam, ab64693) was used in immunohistochemistry - paraffin section on human samples at 1:300 (fig 1c). Oral Dis (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:1000; fig 2c
Abcam Mrc1 antibody (Abcam, ab64693) was used in immunohistochemistry - frozen section on mouse samples at 1:1000 (fig 2c). FASEB J (2018) ncbi
mouse monoclonal (15-2)
  • immunohistochemistry; mouse; loading ...; fig 3b
Abcam Mrc1 antibody (Abcam, ab8918) was used in immunohistochemistry on mouse samples (fig 3b). Oncogene (2018) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 3a
In order to find that activin-follistatin regulation may play a role during the development of experimental autoimmune epididymo-orchitis, Abcam Mrc1 antibody (Abcam, ab64693) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 3a). Sci Rep (2017) ncbi
mouse monoclonal (15-2)
  • immunohistochemistry; rat; loading ...; fig 3l
Abcam Mrc1 antibody (Abcam, Ab8918) was used in immunohistochemistry on rat samples (fig 3l). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; fig s7
Abcam Mrc1 antibody (Abcam, ab64693) was used in immunohistochemistry on mouse samples (fig s7). Cancer Med (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; human; 1:50
Abcam Mrc1 antibody (Abcam, ab64693) was used in immunohistochemistry - frozen section on human samples at 1:50. Nature (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:1000; fig 3
  • immunohistochemistry - paraffin section; mouse; 1:1000; fig 4
In order to characterize the spontaneous peripheral squamous cell lung cancer in mice by ablation of liver X receptors alpha and beta, Abcam Mrc1 antibody (Abcam, ab64693) was used in immunohistochemistry - frozen section on mouse samples at 1:1000 (fig 3) and in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 4). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:2000; fig s2
In order to gain insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade by analysis of immune signatures in longitudinal tumor samples, Abcam Mrc1 antibody (Abcam, Ab64693) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (fig s2). Cancer Discov (2016) ncbi
mouse monoclonal (15-2)
  • western blot; mouse; loading ...; fig 1b
Abcam Mrc1 antibody (Abcam, ab8918) was used in western blot on mouse samples (fig 1b). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - free floating section; mouse; 1:50; fig 9
Abcam Mrc1 antibody (Abcam, AB64693) was used in immunohistochemistry - free floating section on mouse samples at 1:50 (fig 9). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; fig s2
Abcam Mrc1 antibody (Abcam, ab64693) was used in immunohistochemistry - paraffin section on mouse samples (fig s2). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:50; fig 4
Abcam Mrc1 antibody (Abcam, ab64693) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 4). PLoS ONE (2016) ncbi
mouse monoclonal (15-2)
  • flow cytometry; rat; 1:500; fig 3
Abcam Mrc1 antibody (Abcam, ab8918) was used in flow cytometry on rat samples at 1:500 (fig 3). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (EPR6828(B))
  • western blot; human; fig 1
Abcam Mrc1 antibody (Epitomics, 5307) was used in western blot on human samples (fig 1). Oncotarget (2015) ncbi
mouse monoclonal (15-2)
  • flow cytometry; human
Abcam Mrc1 antibody (Abcam, ab8918) was used in flow cytometry on human samples . Int J Mol Sci (2014) ncbi
mouse monoclonal (15-2)
  • immunocytochemistry; mouse
Abcam Mrc1 antibody (Abcam, ab8918) was used in immunocytochemistry on mouse samples . Biomaterials (2014) ncbi
mouse monoclonal (15-2)
  • immunohistochemistry - paraffin section; mouse
Abcam Mrc1 antibody (Abcam, ab8918) was used in immunohistochemistry - paraffin section on mouse samples . PLoS ONE (2013) ncbi
mouse monoclonal (15-2)
  • immunohistochemistry; mouse; tbl 3
  • western blot; mouse; tbl 3
Abcam Mrc1 antibody (Abcam, ab8918) was used in immunohistochemistry on mouse samples (tbl 3) and in western blot on mouse samples (tbl 3). J Neuroimmune Pharmacol (2009) ncbi
Bio-Rad
rat monoclonal (MR5D3)
  • flow cytometry; mouse; 1:100; fig 3d
  • immunohistochemistry; mouse; 1:100; fig 3d
Bio-Rad Mrc1 antibody (Bio-Rad Laboratories, MCA2235A647) was used in flow cytometry on mouse samples at 1:100 (fig 3d) and in immunohistochemistry on mouse samples at 1:100 (fig 3d). J Neuroinflammation (2021) ncbi
rat monoclonal (MR5D3)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 2c
Bio-Rad Mrc1 antibody (Bio-Rad, MCA2235) was used in immunohistochemistry on mouse samples at 1:200 (fig 2c). Front Immunol (2021) ncbi
rat monoclonal (MR5D3)
  • flow cytometry; mouse; 1:300; loading ...; fig 2b
Bio-Rad Mrc1 antibody (Bio-rad, MCA2235A488T) was used in flow cytometry on mouse samples at 1:300 (fig 2b). Int J Mol Sci (2021) ncbi
rat monoclonal (MR5D3)
  • flow cytometry; mouse; fig 3a, 3b
Bio-Rad Mrc1 antibody (Bio-Rad, MCA2235F) was used in flow cytometry on mouse samples (fig 3a, 3b). Diabetes (2021) ncbi
rat monoclonal (MR5D3)
  • immunohistochemistry; mouse; 1:150; loading ...; fig 2d, 4b
Bio-Rad Mrc1 antibody (Biorad, MCA2235T) was used in immunohistochemistry on mouse samples at 1:150 (fig 2d, 4b). elife (2020) ncbi
rat monoclonal (MR5D3)
  • immunohistochemistry; mouse; loading ...; fig 7a
Bio-Rad Mrc1 antibody (BioRad, MCA2235T) was used in immunohistochemistry on mouse samples (fig 7a). Basic Res Cardiol (2020) ncbi
rat monoclonal (MR5D3)
  • immunohistochemistry - free floating section; mouse; 1:1000; loading ...; fig 5b
Bio-Rad Mrc1 antibody (Bio-rad, MR5D3) was used in immunohistochemistry - free floating section on mouse samples at 1:1000 (fig 5b). elife (2020) ncbi
rat monoclonal (MR5D3)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 5c
Bio-Rad Mrc1 antibody (Bio-Rad, MCA2235T) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 5c). Cell Mol Gastroenterol Hepatol (2020) ncbi
rat monoclonal (MR5D3)
  • immunohistochemistry - free floating section; mouse; loading ...; fig s3e
Bio-Rad Mrc1 antibody (BioRad, MCA2235) was used in immunohistochemistry - free floating section on mouse samples (fig s3e). Science (2020) ncbi
rat monoclonal (MR5D3)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 4g
Bio-Rad Mrc1 antibody (bio rad, MR5D3) was used in immunohistochemistry - frozen section on mouse samples (fig 4g). Science (2019) ncbi
rat monoclonal (MR5D3)
  • immunohistochemistry; mouse; 1:100; loading ...; fig 3s2
Bio-Rad Mrc1 antibody (Bio-Rad, MCA2235GA) was used in immunohistochemistry on mouse samples at 1:100 (fig 3s2). elife (2019) ncbi
rat monoclonal (MR5D3)
  • flow cytometry; mouse; loading ...; fig 3c
Bio-Rad Mrc1 antibody (Bio-Rad, MCA2235PET) was used in flow cytometry on mouse samples (fig 3c). Proc Natl Acad Sci U S A (2018) ncbi
rat monoclonal (MR5D3)
  • flow cytometry; mouse; 1:100; fig 5g
In order to test if oncolytic poxvirus treatment improves anti-PD-L1 immunotherapy, Bio-Rad Mrc1 antibody (Bio-Rad, MCA2235F) was used in flow cytometry on mouse samples at 1:100 (fig 5g). Nat Commun (2017) ncbi
rat monoclonal (MR5D3)
  • immunohistochemistry; human; loading ...; fig 1d
Bio-Rad Mrc1 antibody (Serotec, MCA2235) was used in immunohistochemistry on human samples (fig 1d). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (MR5D3)
  • flow cytometry; mouse; fig s1c
In order to show that DNA hypermethylation at the PPARgamma1 promoter is induced by obesity-related factors, Bio-Rad Mrc1 antibody (AbD Serotec, MR5D3) was used in flow cytometry on mouse samples (fig s1c). JCI Insight (2016) ncbi
rat monoclonal (MR5D3)
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...; fig 5b
Bio-Rad Mrc1 antibody (AbD Serotec, MCA2235BT) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 5b). Sci Rep (2016) ncbi
rat monoclonal (MR5D3)
  • immunohistochemistry; mouse; fig s7h
In order to show that tumor-associated macrophages form vascular mimicry channels, Bio-Rad Mrc1 antibody (AbD Serotec, MCA2235) was used in immunohistochemistry on mouse samples (fig s7h). Sci Rep (2016) ncbi
rat monoclonal (MR5D3)
  • flow cytometry; mouse; loading ...; fig st2
In order to demonstrate that plasmalemma vesicle-associated protein governs the seeding of fetal monocyte-derived macrophages in the tissues of mice, Bio-Rad Mrc1 antibody (Abd Serotec, MCA2235A488) was used in flow cytometry on mouse samples (fig st2). Nature (2016) ncbi
rat monoclonal (MR5D3)
  • flow cytometry; mouse; loading ...; fig s2e
In order to investigate how PI3Kgamma regulates macrophage polarization, Bio-Rad Mrc1 antibody (AbD Serotec, MR5D3) was used in flow cytometry on mouse samples (fig s2e). Nature (2016) ncbi
rat monoclonal (MR5D3)
  • flow cytometry; mouse; loading ...; fig s4c
In order to model the expression patterns of chemokines and cytokines that turn into M1/M2 macrophage activation., Bio-Rad Mrc1 antibody (AbD Serotec, MCA2235FB) was used in flow cytometry on mouse samples (fig s4c). PLoS Comput Biol (2016) ncbi
rat monoclonal (MR5D3)
  • immunocytochemistry; mouse; loading ...; fig 2a
Bio-Rad Mrc1 antibody (Serotec, MCA2235) was used in immunocytochemistry on mouse samples (fig 2a). J Neuroinflammation (2016) ncbi
rat monoclonal (MR5D3)
  • immunohistochemistry - frozen section; mouse; 1:500; tbl s1
In order to learn the origin of development of lung macrophage diversity, Bio-Rad Mrc1 antibody (Serotec, MCA2235GA) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (tbl s1). Development (2016) ncbi
rat monoclonal (MR5D3)
  • flow cytometry; mouse; fig 1
In order to investigate how Tregs are maintained in adipose tissue, Bio-Rad Mrc1 antibody (AbD Serotec, MR5D3) was used in flow cytometry on mouse samples (fig 1). Sci Rep (2015) ncbi
rat monoclonal (MR5D3)
  • immunocytochemistry; mouse; 1:500; fig 3
Bio-Rad Mrc1 antibody (Serotec, MCA2235) was used in immunocytochemistry on mouse samples at 1:500 (fig 3). J Neuroinflammation (2015) ncbi
rat monoclonal (MR5D3)
  • flow cytometry; mouse; fig 4
Bio-Rad Mrc1 antibody (AbD Serotec, MCA2235A488) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2015) ncbi
rat monoclonal (MR5D3)
  • flow cytometry; mouse; 1:10; fig 2
In order to test if carbon monoxide suppresses chronic inflammation and leads to metabolic disturbances, Bio-Rad Mrc1 antibody (AbD Serotec, MR5D3) was used in flow cytometry on mouse samples at 1:10 (fig 2). Am J Physiol Endocrinol Metab (2015) ncbi
rat monoclonal (MR5D3)
  • immunocytochemistry; human; 1:50
Bio-Rad Mrc1 antibody (Serotec, MCA2235) was used in immunocytochemistry on human samples at 1:50. Ann Clin Transl Neurol (2014) ncbi
rat monoclonal (MR5D3)
  • immunohistochemistry; mouse; fig 6a
Bio-Rad Mrc1 antibody (Bio-Rad, MCA2235T) was used in immunohistochemistry on mouse samples (fig 6a). Mol Cancer Ther (2015) ncbi
rat monoclonal (MR5D3)
  • immunohistochemistry - free floating section; mouse; 1:500; tbl 1
Bio-Rad Mrc1 antibody (AbD Serotec, MCA2235GA) was used in immunohistochemistry - free floating section on mouse samples at 1:500 (tbl 1). Brain Behav Immun (2015) ncbi
rat monoclonal (MR5D3)
  • flow cytometry; mouse; fig 4
Bio-Rad Mrc1 antibody (AbD Serotec, MR5D3) was used in flow cytometry on mouse samples (fig 4). J Leukoc Biol (2015) ncbi
rat monoclonal (MR5D3)
  • immunocytochemistry; mouse; fig 3
In order to investigate the use of mannosylated synthetic long peptides for vaccination, Bio-Rad Mrc1 antibody (AbD Serotec, MR5D3) was used in immunocytochemistry on mouse samples (fig 3). PLoS ONE (2014) ncbi
rat monoclonal (MR5D3)
  • flow cytometry; human
Bio-Rad Mrc1 antibody (AbDSerotec, MR5D3) was used in flow cytometry on human samples . Cancer Res (2014) ncbi
rat monoclonal (MR5D3)
  • flow cytometry; mouse; 1:300
Bio-Rad Mrc1 antibody (AbD Serotec, McA2235A647T) was used in flow cytometry on mouse samples at 1:300. PLoS ONE (2014) ncbi
rat monoclonal (MR5D3)
  • immunohistochemistry - frozen section; mouse; 1:500
Bio-Rad Mrc1 antibody (AbD Serotec, MCA2235) was used in immunohistochemistry - frozen section on mouse samples at 1:500. J Comp Neurol (2014) ncbi
rat monoclonal (MR5D3)
  • immunohistochemistry - paraffin section; mouse
Bio-Rad Mrc1 antibody (Abdserotec, MCA2235GA) was used in immunohistochemistry - paraffin section on mouse samples . PLoS ONE (2013) ncbi
rat monoclonal (MR5D3)
  • immunohistochemistry - paraffin section; mouse; 1:25
Bio-Rad Mrc1 antibody (AbD Serotec, MCA2235) was used in immunohistochemistry - paraffin section on mouse samples at 1:25. Cell Transplant (2014) ncbi
rat monoclonal (MR5D3)
  • immunohistochemistry; mouse; tbl 3
  • western blot; mouse; tbl 3
Bio-Rad Mrc1 antibody (AbD Serotec, MCA2235) was used in immunohistochemistry on mouse samples (tbl 3) and in western blot on mouse samples (tbl 3). J Neuroimmune Pharmacol (2009) ncbi
Invitrogen
rat monoclonal (MR6F3)
  • flow cytometry; mouse; 1:1000; loading ...; fig 2b, 2c
Invitrogen Mrc1 antibody (Invitrogen, 12-2061-82) was used in flow cytometry on mouse samples at 1:1000 (fig 2b, 2c). Theranostics (2022) ncbi
rat monoclonal (MR6F3)
  • flow cytometry; mouse; 1:200; loading ...; fig s1d
Invitrogen Mrc1 antibody (eBioscience, 47-2061-82) was used in flow cytometry on mouse samples at 1:200 (fig s1d). Immunity (2022) ncbi
rat monoclonal (MR6F3)
  • flow cytometry; mouse; 1:100; loading ...; fig 4d
Invitrogen Mrc1 antibody (Invitrogen, MR6F3) was used in flow cytometry on mouse samples at 1:100 (fig 4d). Immunol Cell Biol (2022) ncbi
rat monoclonal (MR6F3)
  • flow cytometry; mouse; 1:100; loading ...; fig 2c, e2i, 5e, e4j
Invitrogen Mrc1 antibody (eBioscience, 12-2061-80) was used in flow cytometry on mouse samples at 1:100 (fig 2c, e2i, 5e, e4j). EMBO Mol Med (2022) ncbi
rat monoclonal (MR6F3)
  • flow cytometry; mouse; fig s3c
Invitrogen Mrc1 antibody (eBioscience, 56-2061-82) was used in flow cytometry on mouse samples (fig s3c). Mol Cancer (2021) ncbi
rat monoclonal (MR5D3)
  • flow cytometry; mouse; 1:50; loading ...; fig s2
Invitrogen Mrc1 antibody (Thermo Fisher, MA516870) was used in flow cytometry on mouse samples at 1:50 (fig s2). Front Immunol (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; loading ...; fig 3k
Invitrogen Mrc1 antibody (Invitrogen, PA5?\101657) was used in immunohistochemistry on mouse samples (fig 3k). J Am Heart Assoc (2021) ncbi
rat monoclonal (MR6F3)
  • flow cytometry; mouse; loading ...; fig 4a
Invitrogen Mrc1 antibody (eBioscience, 12-2061-80) was used in flow cytometry on mouse samples (fig 4a). Commun Biol (2021) ncbi
rat monoclonal (MR6F3)
  • flow cytometry; human; loading ...; fig s4b
Invitrogen Mrc1 antibody (EBioscience, 12-2061-80) was used in flow cytometry on human samples (fig s4b). Breast Cancer Res (2019) ncbi
rat monoclonal (MR6F3)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 2f
In order to assess the role of pigment epithelium-derived factor in macrophage recruitment and polarization, Invitrogen Mrc1 antibody (eBiosciences, 12-2061-80) was used in immunohistochemistry - frozen section on mouse samples (fig 2f). Sci Rep (2017) ncbi
rat monoclonal (MR5D3)
  • flow cytometry; mouse; 2.5 ug/ml; fig 9
In order to investigate if microRNAs contribute to macrophage's fibrogenesis, Invitrogen Mrc1 antibody (Thermo, MA5?C16870) was used in flow cytometry on mouse samples at 2.5 ug/ml (fig 9). Nat Commun (2015) ncbi
Santa Cruz Biotechnology
mouse monoclonal (15-2)
  • immunohistochemistry; rat; 1:50; loading ...; fig 6a
  • western blot; rat; 1:1000; loading ...; fig 1a
Santa Cruz Biotechnology Mrc1 antibody (Santa Cruz Biotechnology, sc-58986) was used in immunohistochemistry on rat samples at 1:50 (fig 6a) and in western blot on rat samples at 1:1000 (fig 1a). J Neuroinflammation (2021) ncbi
mouse monoclonal (15-2)
  • immunohistochemistry - paraffin section; mouse; 1:50; loading ...; fig 8g
Santa Cruz Biotechnology Mrc1 antibody (Santa, sc58986) was used in immunohistochemistry - paraffin section on mouse samples at 1:50 (fig 8g). PLoS Pathog (2020) ncbi
mouse monoclonal (15-2)
  • immunocytochemistry; human; loading ...; fig 2f
Santa Cruz Biotechnology Mrc1 antibody (Santa Cruz Biotech, SC-58986) was used in immunocytochemistry on human samples (fig 2f). Sci Transl Med (2020) ncbi
R&D Systems
domestic goat polyclonal
  • immunohistochemistry - paraffin section; mouse; fig s7f
R&D Systems Mrc1 antibody (R&D, AF2535) was used in immunohistochemistry - paraffin section on mouse samples (fig s7f). Cell Rep (2022) ncbi
domestic goat polyclonal
  • immunohistochemistry - frozen section; mouse; 1:500; loading ...; fig 5c
R&D Systems Mrc1 antibody (R&D, AF2535) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 5c). Stroke Vasc Neurol (2021) ncbi
domestic goat polyclonal
  • flow cytometry; mouse; loading ...; fig 5e
R&D Systems Mrc1 antibody (R&D Systems, AF2535) was used in flow cytometry on mouse samples (fig 5e). Front Immunol (2021) ncbi
domestic goat polyclonal
  • immunohistochemistry; mouse; 1:50; loading ...; fig s3b
R&D Systems Mrc1 antibody (R&D Systems, AF2535) was used in immunohistochemistry on mouse samples at 1:50 (fig s3b). Diabetologia (2021) ncbi
domestic goat polyclonal
  • immunohistochemistry; mouse; 1:100
R&D Systems Mrc1 antibody (R&D Systems, AF2535) was used in immunohistochemistry on mouse samples at 1:100. J Reprod Immunol (2021) ncbi
domestic goat polyclonal
  • immunocytochemistry; mouse; 1:500; loading ...; fig 1a
R&D Systems Mrc1 antibody (R&D System, AF2535) was used in immunocytochemistry on mouse samples at 1:500 (fig 1a). Theranostics (2021) ncbi
Aviva Systems Biology
rat monoclonal (MR5D3)
In order to examine the role of lysosome associated membrane proteins in pancreatitis, Aviva Systems Biology Mrc1 antibody (Aviva Systems Biology, OASA05048) was used . Cell Mol Gastroenterol Hepatol (2015) ncbi
Articles Reviewed
  1. Beider K, Voevoda Dimenshtein V, Zoabi A, Rosenberg E, Magen H, Ostrovsky O, et al. CXCL13 chemokine is a novel player in multiple myeloma osteolytic microenvironment, M2 macrophage polarization, and tumor progression. J Hematol Oncol. 2022;15:144 pubmed publisher
  2. Yang P, Qin H, Li Y, Xiao A, Zheng E, Zeng H, et al. CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis. Nat Commun. 2022;13:5782 pubmed publisher
  3. Cao S, Hung Y, Wang Y, Chung Y, Qi Y, Ouyang C, et al. Glutamine is essential for overcoming the immunosuppressive microenvironment in malignant salivary gland tumors. Theranostics. 2022;12:6038-6056 pubmed publisher
  4. El Naccache D, Chen F, Palma M, Lemenze A, Fischer M, Wu W, et al. Adenosine metabolized from extracellular ATP promotes type 2 immunity through triggering A2BAR signaling in intestinal epithelial cells. Cell Rep. 2022;40:111150 pubmed publisher
  5. Yang M, Xiong J, Zou Q, Wang X, Hu K, Zhao Q. Sinapic Acid Attenuated Cardiac Remodeling After Myocardial Infarction by Promoting Macrophage M2 Polarization Through the PPARγ Pathway. Front Cardiovasc Med. 2022;9:915903 pubmed publisher
  6. Wang F, Li M, Zhang A, Li H, Jiang C, Guo J. PCSK9 Modulates Macrophage Polarization-Mediated Ventricular Remodeling after Myocardial Infarction. J Immunol Res. 2022;2022:7685796 pubmed publisher
  7. Zhang L, Zheng D, Yan Y, Yu Y, Chen R, Li Z, et al. Myeloid cell-specific deletion of Capns1 prevents macrophage polarization toward the M1 phenotype and reduces interstitial lung disease in the bleomycin model of systemic sclerosis. Arthritis Res Ther. 2022;24:148 pubmed publisher
  8. Kawakubo A, Miyagi M, Yokozeki Y, Nakawaki M, Takano S, Satoh M, et al. Origin of M2 Mϕ and its macrophage polarization by TGF-β in a mice intervertebral injury model. Int J Immunopathol Pharmacol. 2022;36:3946320221103792 pubmed publisher
  9. Pan C, Wu Q, Wang S, Mei Z, Zhang L, Gao X, et al. Combination with Toll-like receptor 4 (TLR4) agonist reverses GITR agonism mediated M2 polarization of macrophage in Hepatocellular carcinoma. Oncoimmunology. 2022;11:2073010 pubmed publisher
  10. Melese E, Franks E, Cederberg R, Harbourne B, Shi R, Wadsworth B, et al. CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development. Oncoimmunology. 2022;11:2010905 pubmed publisher
  11. Cortes J, Filip I, Albero R, Patiño Galindo J, Quinn S, Lin W, et al. Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma. Cell Rep. 2022;39:110695 pubmed publisher
  12. Larue M, Parker S, Puccini J, Cammer M, Kimmelman A, Bar Sagi D. Metabolic reprogramming of tumor-associated macrophages by collagen turnover promotes fibrosis in pancreatic cancer. Proc Natl Acad Sci U S A. 2022;119:e2119168119 pubmed publisher
  13. Chen K, Hu Q, Xie Z, Yang G. Monocyte NLRP3-IL-1β Hyperactivation Mediates Neuronal and Synaptic Dysfunction in Perioperative Neurocognitive Disorder. Adv Sci (Weinh). 2022;9:e2104106 pubmed publisher
  14. Yang J, Zhang Q, Wang J, Lou Y, Hong Z, Wei S, et al. Dynamic profiling of immune microenvironment during pancreatic cancer development suggests early intervention and combination strategy of immunotherapy. EBioMedicine. 2022;78:103958 pubmed publisher
  15. Günes Günsel G, Conlon T, Jeridi A, Kim R, Ertuz Z, Lang N, et al. The arginine methyltransferase PRMT7 promotes extravasation of monocytes resulting in tissue injury in COPD. Nat Commun. 2022;13:1303 pubmed publisher
  16. Simpson D, Pang J, Weir A, Kong I, Fritsch M, Rashidi M, et al. Interferon-γ primes macrophages for pathogen ligand-induced killing via a caspase-8 and mitochondrial cell death pathway. Immunity. 2022;55:423-441.e9 pubmed publisher
  17. Clayer E, Frank D, Anderton H, Zhang S, Kueh A, Heim V, et al. ZC3H12C expression in dendritic cells is necessary to prevent lymphadenopathy of skin-draining lymph nodes. Immunol Cell Biol. 2022;100:160-173 pubmed publisher
  18. Theruvath J, Ménard M, Smith B, Linde M, Coles G, Dalton G, et al. Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication. Nat Med. 2022;28:333-344 pubmed publisher
  19. Zhou Q, Liang J, Yang T, Liu J, Li B, Li Y, et al. Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer. EMBO Mol Med. 2022;14:e14502 pubmed publisher
  20. Bhattacharjee O, Ayyangar U, Kurbet A, Lakshmanan V, Palakodeti D, Ginhoux F, et al. Epithelial-Macrophage Crosstalk Initiates Sterile Inflammation in Embryonic Skin. Front Immunol. 2021;12:718005 pubmed publisher
  21. Yu S, Cheng L, Tian D, Li Z, Yao F, Luo Y, et al. Fascin-1 is Highly Expressed Specifically in Microglia After Spinal Cord Injury and Regulates Microglial Migration. Front Pharmacol. 2021;12:729524 pubmed publisher
  22. Zheng Z, Chen J, Lyu H, Lam S, Lu G, Chan W, et al. Novel role of STAT3 in microglia-dependent neuroinflammation after experimental subarachnoid haemorrhage. Stroke Vasc Neurol. 2021;: pubmed publisher
  23. Van Maldegem F, Valand K, Cole M, Patel H, Angelova M, Rana S, et al. Characterisation of tumour microenvironment remodelling following oncogene inhibition in preclinical studies with imaging mass cytometry. Nat Commun. 2021;12:5906 pubmed publisher
  24. Kiepura A, Stachyra K, Wisniewska A, Kus K, Czepiel K, Suski M, et al. The Anti-Atherosclerotic Action of FFAR4 Agonist TUG-891 in ApoE-Knockout Mice Is Associated with Increased Macrophage Polarization towards M2 Phenotype. Int J Mol Sci. 2021;22: pubmed publisher
  25. Zhang P, Schlecht A, Wolf J, Boneva S, Laich Y, Koch J, et al. The role of interferon regulatory factor 8 for retinal tissue homeostasis and development of choroidal neovascularisation. J Neuroinflammation. 2021;18:215 pubmed publisher
  26. Yang C, Lei L, Collins J, Briones M, Ma L, Sturdevant G, et al. Chlamydia evasion of neutrophil host defense results in NLRP3 dependent myeloid-mediated sterile inflammation through the purinergic P2X7 receptor. Nat Commun. 2021;12:5454 pubmed publisher
  27. Jiao B, An C, Tran M, Du H, Wang P, Zhou D, et al. Pharmacological Inhibition of STAT6 Ameliorates Myeloid Fibroblast Activation and Alternative Macrophage Polarization in Renal Fibrosis. Front Immunol. 2021;12:735014 pubmed publisher
  28. Gredic M, Wu C, Hadžić S, Pak O, Savai R, Kojonazarov B, et al. Myeloid cell-specific deletion of inducible nitric oxide synthase protects against smoke-induced pulmonary hypertension in mice. Eur Respir J. 2021;: pubmed publisher
  29. Drzyzga A, Cichon T, Czapla J, Jarosz Biej M, Pilny E, Matuszczak S, et al. The Proper Administration Sequence of Radiotherapy and Anti-Vascular Agent-DMXAA Is Essential to Inhibit the Growth of Melanoma Tumors. Cancers (Basel). 2021;13: pubmed publisher
  30. Liu Z, Wang T, She Y, Wu K, Gu S, Li L, et al. N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. Mol Cancer. 2021;20:105 pubmed publisher
  31. Guo E, Mao X, Wang X, Guo L, An C, Zhang C, et al. Alternatively spliced ANLN isoforms synergistically contribute to the progression of head and neck squamous cell carcinoma. Cell Death Dis. 2021;12:764 pubmed publisher
  32. Forman R, Logunova L, Smith H, Wemyss K, Mair I, Boon L, et al. Trichuris muris infection drives cell-intrinsic IL4R alpha independent colonic RELMα+ macrophages. PLoS Pathog. 2021;17:e1009768 pubmed publisher
  33. Lu C, Liu Z, Klement J, Yang D, Merting A, Poschel D, et al. WDR5-H3K4me3 epigenetic axis regulates OPN expression to compensate PD-L1 function to promote pancreatic cancer immune escape. J Immunother Cancer. 2021;9: pubmed publisher
  34. Gao D, Salomonis N, Henderlight M, Woods C, Thakkar K, Grom A, et al. IFN-γ is essential for alveolar macrophage-driven pulmonary inflammation in macrophage activation syndrome. JCI Insight. 2021;6: pubmed publisher
  35. Mathä L, Romera Hernandez M, Steer C, Yin Y, Orangi M, Shim H, et al. Migration of Lung Resident Group 2 Innate Lymphoid Cells Link Allergic Lung Inflammation and Liver Immunity. Front Immunol. 2021;12:679509 pubmed publisher
  36. Okamura T, Hashimoto Y, Mori J, Yamaguchi M, Majima S, Senmaru T, et al. ILC2s Improve Glucose Metabolism Through the Control of Saturated Fatty Acid Absorption Within Visceral Fat. Front Immunol. 2021;12:669629 pubmed publisher
  37. Van De Velde L, Allen E, Crawford J, Wilson T, Guy C, Russier M, et al. Neuroblastoma Formation Requires Unconventional CD4 T Cells and Arginase-1-Dependent Myeloid Cells. Cancer Res. 2021;81:5047-5059 pubmed publisher
  38. Xiao J, Cai T, Fang Y, Liu R, Flores J, Wang W, et al. Activation of GPR40 attenuates neuroinflammation and improves neurological function via PAK4/CREB/KDM6B pathway in an experimental GMH rat model. J Neuroinflammation. 2021;18:160 pubmed publisher
  39. Lu J, Wang W, Li P, Wang X, Gao C, Zhang B, et al. MiR-146a regulates regulatory T cells to suppress heart transplant rejection in mice. Cell Death Discov. 2021;7:165 pubmed publisher
  40. Xie C, Ye F, Zhang N, Huang Y, Pan Y, Xie X. CCL7 contributes to angiotensin II-induced abdominal aortic aneurysm by promoting macrophage infiltration and pro-inflammatory phenotype. J Cell Mol Med. 2021;25:7280-7293 pubmed publisher
  41. Cai C, Zeng D, Gao Q, Ma L, Zeng B, Zhou Y, et al. Decreased ferroportin in hepatocytes promotes macrophages polarize towards an M2-like phenotype and liver fibrosis. Sci Rep. 2021;11:13386 pubmed publisher
  42. Janssens P, Decuypere J, De Rechter S, Breysem L, Van Giel D, Billen J, et al. Enhanced MCP-1 Release in Early Autosomal Dominant Polycystic Kidney Disease. Kidney Int Rep. 2021;6:1687-1698 pubmed publisher
  43. Jiang T, Xu S, Shen Y, Xu Y, Li Y. Genistein Attenuates Isoflurane-Induced Neuroinflammation by Inhibiting TLR4-Mediated Microglial-Polarization in vivo and in vitro. J Inflamm Res. 2021;14:2587-2600 pubmed publisher
  44. Nordlohne J, Hulsmann I, Schwafertz S, Zgrajek J, Grundmann M, von Vietinghoff S, et al. A flow cytometry approach reveals heterogeneity in conventional subsets of murine renal mononuclear phagocytes. Sci Rep. 2021;11:13251 pubmed publisher
  45. Tian X, Wang Y, Lu Y, Wang W, Du J, Chen S, et al. Conditional depletion of macrophages ameliorates cholestatic liver injury and fibrosis via lncRNA-H19. Cell Death Dis. 2021;12:646 pubmed publisher
  46. Glausen T, Carrillo G, Jin R, Boyle J, Saeij J, Wohlfert E, et al. The Toxoplasma Polymorphic Effector GRA15 Mediates Seizure Induction by Modulating Interleukin-1 Signaling in the Brain. MBio. 2021;12:e0133121 pubmed publisher
  47. Tan H, Song Y, Chen J, Zhang N, Wang Q, Li Q, et al. Platelet-Like Fusogenic Liposome-Mediated Targeting Delivery of miR-21 Improves Myocardial Remodeling by Reprogramming Macrophages Post Myocardial Ischemia-Reperfusion Injury. Adv Sci (Weinh). 2021;8:e2100787 pubmed publisher
  48. Al Zaeed N, Budai Z, Szondy Z, Sarang Z. TAM kinase signaling is indispensable for proper skeletal muscle regeneration in mice. Cell Death Dis. 2021;12:611 pubmed publisher
  49. Basse A, Agerholm M, Farup J, Dalbram E, Nielsen J, Ørtenblad N, et al. Nampt controls skeletal muscle development by maintaining Ca2+ homeostasis and mitochondrial integrity. Mol Metab. 2021;53:101271 pubmed publisher
  50. Li J, Sun Z, Luo G, Wang S, Cui H, Yao Z, et al. Quercetin Attenuates Trauma-Induced Heterotopic Ossification by Tuning Immune Cell Infiltration and Related Inflammatory Insult. Front Immunol. 2021;12:649285 pubmed publisher
  51. Yan C, Saleh N, Yang J, Nebhan C, Vilgelm A, Reddy E, et al. Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade. Mol Cancer. 2021;20:85 pubmed publisher
  52. Götz P, Braumandl A, Kübler M, Kumaraswami K, Ishikawa Ankerhold H, Lasch M, et al. C3 Deficiency Leads to Increased Angiogenesis and Elevated Pro-Angiogenic Leukocyte Recruitment in Ischemic Muscle Tissue. Int J Mol Sci. 2021;22: pubmed publisher
  53. Chen L, Cheng S, Sun K, Wang J, Liu X, Zhao Y, et al. Changes in macrophage and inflammatory cytokine expressions during fracture healing in an ovariectomized mice model. BMC Musculoskelet Disord. 2021;22:494 pubmed publisher
  54. Miura I, Komine S, Okada K, Wada S, Warabi E, Uchida F, et al. Prevention of non-alcoholic steatohepatitis by long-term exercise via the induction of phenotypic changes in Kupffer cells of hyperphagic obese mice. Physiol Rep. 2021;9:e14859 pubmed publisher
  55. Lindfors S, Polianskyte Prause Z, Bouslama R, Lehtonen E, Mannerla M, Nisen H, et al. Adiponectin receptor agonist AdipoRon ameliorates renal inflammation in diet-induced obese mice and endotoxin-treated human glomeruli ex vivo. Diabetologia. 2021;64:1866-1879 pubmed publisher
  56. Amoozgar Z, Kloepper J, Ren J, Tay R, Kazer S, Kiner E, et al. Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas. Nat Commun. 2021;12:2582 pubmed publisher
  57. Li N, Zhao S, Zhang Z, Zhu Y, Gliniak C, Vishvanath L, et al. Adiponectin preserves metabolic fitness during aging. elife. 2021;10: pubmed publisher
  58. Genestine M, Ambriz D, Crabtree G, Dummer P, Molotkova A, Quintero M, et al. Vascular-derived SPARC and SerpinE1 regulate interneuron tangential migration and accelerate functional maturation of human stem cell-derived interneurons. elife. 2021;10: pubmed publisher
  59. Andriessen E, Binet F, Fournier F, Hata M, Dejda A, Mawambo G, et al. Myeloid-resident neuropilin-1 promotes choroidal neovascularization while mitigating inflammation. EMBO Mol Med. 2021;13:e11754 pubmed publisher
  60. Zhou J, Pei X, Yang Y, Wang Z, Gao W, Ye R, et al. Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in glioma. J Immunother Cancer. 2021;9: pubmed publisher
  61. Gangoso E, Southgate B, Bradley L, Rus S, Gálvez Cancino F, McGivern N, et al. Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion. Cell. 2021;184:2454-2470.e26 pubmed publisher
  62. Wu T, Liu Q, Li Y, Li H, Chen L, Yang X, et al. Feeding-induced hepatokine, Manf, ameliorates diet-induced obesity by promoting adipose browning via p38 MAPK pathway. J Exp Med. 2021;218: pubmed publisher
  63. Manrique Acevedo C, Padilla J, Naz H, Woodford M, Ghiarone T, Aroor A, et al. Mineralocorticoid Receptor in Myeloid Cells Mediates Angiotensin II-Induced Vascular Dysfunction in Female Mice. Front Physiol. 2021;12:588358 pubmed publisher
  64. Saunders D, Aamodt K, Richardson T, Hopkirk A, Aramandla R, Poffenberger G, et al. Coordinated interactions between endothelial cells and macrophages in the islet microenvironment promote β cell regeneration. NPJ Regen Med. 2021;6:22 pubmed publisher
  65. Roux C, Mucciolo G, Kopecka J, Novelli F, Riganti C, Cappello P. IL17A Depletion Affects the Metabolism of Macrophages Treated with Gemcitabine. Antioxidants (Basel). 2021;10: pubmed publisher
  66. Chu A, Kok S, TSUI J, Lin M, Aguirre B, Wadehra M. Epithelial membrane protein 2 (Emp2) modulates innate immune cell population recruitment at the maternal-fetal interface. J Reprod Immunol. 2021;145:103309 pubmed publisher
  67. Zhou M, Wang X, Shi Y, Ding Y, Li X, Xie T, et al. Deficiency of ITGAM Attenuates Experimental Abdominal Aortic Aneurysm in Mice. J Am Heart Assoc. 2021;10:e019900 pubmed publisher
  68. Xiao Y, Shu L, Wu X, Liu Y, Cheong L, Liao B, et al. Fatty acid binding protein 4 promotes autoimmune diabetes by recruitment and activation of pancreatic islet macrophages. JCI Insight. 2021;6: pubmed publisher
  69. Mao F, Lv Y, Hao C, Teng Y, Liu Y, Cheng P, et al. Helicobacter pylori-Induced Rev-erbα Fosters Gastric Bacteria Colonization by Impairing Host Innate and Adaptive Defense. Cell Mol Gastroenterol Hepatol. 2021;12:395-425 pubmed publisher
  70. Santos Zas I, Lemari xe9 J, Zlatanova I, Cachanado M, Seghezzi J, Benamer H, et al. Cytotoxic CD8+ T cells promote granzyme B-dependent adverse post-ischemic cardiac remodeling. Nat Commun. 2021;12:1483 pubmed publisher
  71. Bakker W, Dingenouts C, Lodder K, Wiesmeijer K, de Jong A, Kurakula K, et al. BMP Receptor Inhibition Enhances Tissue Repair in Endoglin Heterozygous Mice. Int J Mol Sci. 2021;22: pubmed publisher
  72. Yin H, Zhang X, Yang P, Zhang X, Peng Y, Li D, et al. RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming. Nat Commun. 2021;12:1394 pubmed publisher
  73. Wolfsberger J, Sakil H, Zhou L, van Bree N, Baldisseri E, de Souza Ferreira S, et al. TAp73 represses NF-κB-mediated recruitment of tumor-associated macrophages in breast cancer. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  74. Zheng H, Zhang Y, Li L, Zhang R, Luo Z, Yang Z, et al. Depletion of Toll-Like Receptor-9 Attenuates Renal Tubulointerstitial Fibrosis After Ischemia-Reperfusion Injury. Front Cell Dev Biol. 2021;9:641527 pubmed publisher
  75. Zarb Y, Sridhar S, Nassiri S, Utz S, Schaffenrath J, Maheshwari U, et al. Microglia control small vessel calcification via TREM2. Sci Adv. 2021;7: pubmed publisher
  76. Zhang Y, Liu J, Wang X, Zhang J, Xie C. Extracellular vesicle-encapsulated microRNA-23a from dorsal root ganglia neurons binds to A20 and promotes inflammatory macrophage polarization following peripheral nerve injury. Aging (Albany NY). 2021;13:6752-6764 pubmed publisher
  77. Chen J, Cao X, Li B, Zhao Z, Chen S, Lai S, et al. Warburg Effect Is a Cancer Immune Evasion Mechanism Against Macrophage Immunosurveillance. Front Immunol. 2020;11:621757 pubmed publisher
  78. Song L, Chang R, Sun X, Lu L, Gao H, Lu H, et al. Macrophage-derived EDA-A2 inhibits intestinal stem cells by targeting miR-494/EDA2R/β-catenin signaling in mice. Commun Biol. 2021;4:213 pubmed publisher
  79. Mpekris F, Panagi M, Voutouri C, Martin J, Samuel R, Takahashi S, et al. Normalizing the Microenvironment Overcomes Vessel Compression and Resistance to Nano-immunotherapy in Breast Cancer Lung Metastasis. Adv Sci (Weinh). 2021;8:2001917 pubmed publisher
  80. Ali S, Borin T, Piranlioglu R, Ara R, Lebedyeva I, Angara K, et al. Changes in the tumor microenvironment and outcome for TME-targeting therapy in glioblastoma: A pilot study. PLoS ONE. 2021;16:e0246646 pubmed publisher
  81. Ni X, Zhang Y, Jia L, Lu W, Zhu Q, Ren J, et al. Inhibition of Notch1-mediated inflammation by intermedin protects against abdominal aortic aneurysm via PI3K/Akt signaling pathway. Aging (Albany NY). 2021;13:5164-5184 pubmed publisher
  82. Rudloff S, Janot M, Rodriguez S, Dessalle K, Jahnen Dechent W, Huynh Do U. Fetuin-A is a HIF target that safeguards tissue integrity during hypoxic stress. Nat Commun. 2021;12:549 pubmed publisher
  83. Tyagi A, Sharma S, Wu K, Wu S, Xing F, Liu Y, et al. Nicotine promotes breast cancer metastasis by stimulating N2 neutrophils and generating pre-metastatic niche in lung. Nat Commun. 2021;12:474 pubmed publisher
  84. Mastorakos P, Mihelson N, Luby M, Burks S, Johnson K, Hsia A, et al. Temporally distinct myeloid cell responses mediate damage and repair after cerebrovascular injury. Nat Neurosci. 2021;24:245-258 pubmed publisher
  85. Ogura Y, Tajiri K, Murakoshi N, Xu D, Yonebayashi S, Li S, et al. Neutrophil Elastase Deficiency Ameliorates Myocardial Injury Post Myocardial Infarction in Mice. Int J Mol Sci. 2021;22: pubmed publisher
  86. Li Z, Song Y, He T, Wen R, Li Y, Chen T, et al. M2 microglial small extracellular vesicles reduce glial scar formation via the miR-124/STAT3 pathway after ischemic stroke in mice. Theranostics. 2021;11:1232-1248 pubmed publisher
  87. Antony A, Lian Z, Perrard X, Perrard J, Liu H, Cox A, et al. Deficiency of Stat1 in CD11c+ Cells Alters Adipose Tissue Inflammation and Improves Metabolic Dysfunctions in Mice Fed a High-Fat Diet. Diabetes. 2021;70:720-732 pubmed publisher
  88. Boulet N, Luijten I, Cannon B, Nedergaard J. Thermogenic recruitment of brown and brite/beige adipose tissues is not obligatorily associated with macrophage accretion or attrition. Am J Physiol Endocrinol Metab. 2020;: pubmed publisher
  89. Mia M, Cibi D, Abdul Ghani S, Song W, Tee N, Ghosh S, et al. YAP/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction. PLoS Biol. 2020;18:e3000941 pubmed publisher
  90. Wu S, Xu R, Zhu X, He H, Zhang J, Zeng Q, et al. The long noncoding RNA LINC01140/miR-140-5p/FGF9 axis modulates bladder cancer cell aggressiveness and macrophage M2 polarization. Aging (Albany NY). 2020;12:25845-25864 pubmed publisher
  91. Luo Z, Ji Y, Gao H, Gomes Dos Reis F, Bandyopadhyay G, Jin Z, et al. CRIg+ Macrophages Prevent Gut Microbial DNA-Containing Extracellular Vesicle-Induced Tissue Inflammation and Insulin Resistance. Gastroenterology. 2021;160:863-874 pubmed publisher
  92. Myers D, Abram C, Wildes D, Belwafa A, Welsh A, Schulze C, et al. Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity. Front Immunol. 2020;11:576310 pubmed publisher
  93. Hall B, Gleiberman A, Strom E, Krasnov P, Frescas D, Vujcic S, et al. Immune checkpoint protein VSIG4 as a biomarker of aging in murine adipose tissue. Aging Cell. 2020;19:e13219 pubmed publisher
  94. Oguri Y, Shinoda K, Kim H, Alba D, Bolus W, Wang Q, et al. CD81 Controls Beige Fat Progenitor Cell Growth and Energy Balance via FAK Signaling. Cell. 2020;: pubmed publisher
  95. McKinsey G, Lizama C, Keown Lang A, Niu A, Santander N, Larpthaveesarp A, et al. A new genetic strategy for targeting microglia in development and disease. elife. 2020;9: pubmed publisher
  96. Lubos N, van der Gaag S, Gerçek M, Kant S, Leube R, Krusche C. Inflammation shapes pathogenesis of murine arrhythmogenic cardiomyopathy. Basic Res Cardiol. 2020;115:42 pubmed publisher
  97. Witschen P, Chaffee T, Brady N, Huggins D, Knutson T, LaRue R, et al. Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast Cancer. Cancers (Basel). 2020;12: pubmed publisher
  98. Burfeind K, Zhu X, Norgard M, Levasseur P, Huisman C, Buenafe A, et al. Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer. elife. 2020;9: pubmed publisher
  99. Zheng D, Gao F, Cheng Q, Bao P, Dong X, Fan J, et al. A vaccine-based nanosystem for initiating innate immunity and improving tumor immunotherapy. Nat Commun. 2020;11:1985 pubmed publisher
  100. Choudhuri S, Garg N. PARP1-cGAS-NF-κB pathway of proinflammatory macrophage activation by extracellular vesicles released during Trypanosoma cruzi infection and Chagas disease. PLoS Pathog. 2020;16:e1008474 pubmed publisher
  101. Chao Y, Liang C, Tao H, Du Y, Wu D, Dong Z, et al. Localized cocktail chemoimmunotherapy after in situ gelation to trigger robust systemic antitumor immune responses. Sci Adv. 2020;6:eaaz4204 pubmed publisher
  102. Kapralov A, Yang Q, Dar H, Tyurina Y, Anthonymuthu T, Kim R, et al. Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death. Nat Chem Biol. 2020;16:278-290 pubmed publisher
  103. Adams C, Ercolano E, Ferluga S, Sofela A, Dave F, Negroni C, et al. A Rapid Robust Method for Subgrouping Non-NF2 Meningiomas According to Genotype and Detection of Lower Levels of M2 Macrophages in AKT1 E17K Mutated Tumours. Int J Mol Sci. 2020;21: pubmed publisher
  104. Jaynes J, Sable R, Ronzetti M, Bautista W, Knotts Z, Abisoye Ogunniyan A, et al. Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses. Sci Transl Med. 2020;12: pubmed publisher
  105. Cohen G, Chandran P, Lorsung R, Tomlinson L, Sundby M, Burks S, et al. The Impact of Focused Ultrasound in Two Tumor Models: Temporal Alterations in the Natural History on Tumor Microenvironment and Immune Cell Response. Cancers (Basel). 2020;12: pubmed publisher
  106. Ali S, Mansour A, Huang W, Queen N, Mo X, Anderson J, et al. CSF1R inhibitor PLX5622 and environmental enrichment additively improve metabolic outcomes in middle-aged female mice. Aging (Albany NY). 2020;12:2101-2122 pubmed publisher
  107. Terashima Y, Toda E, Itakura M, Otsuji M, Yoshinaga S, Okumura K, et al. Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties. Nat Commun. 2020;11:609 pubmed publisher
  108. Orgaz J, Crosas Molist E, Sadok A, Perdrix Rosell A, Maiques O, Rodriguez Hernandez I, et al. Myosin II Reactivation and Cytoskeletal Remodeling as a Hallmark and a Vulnerability in Melanoma Therapy Resistance. Cancer Cell. 2020;37:85-103.e9 pubmed publisher
  109. Cai S, Ge M, Mennone A, Hoque R, Ouyang X, Boyer J. Inflammasome Is Activated in the Liver of Cholestatic Patients and Aggravates Hepatic Injury in Bile Duct-Ligated Mouse. Cell Mol Gastroenterol Hepatol. 2020;9:679-688 pubmed publisher
  110. Cserép C, Pósfai B, Lénárt N, Fekete R, László Z, Lele Z, et al. Microglia monitor and protect neuronal function through specialized somatic purinergic junctions. Science. 2020;367:528-537 pubmed publisher
  111. Shibata Germanos S, Goodman J, Grieg A, Trivedi C, Benson B, Foti S, et al. Structural and functional conservation of non-lumenized lymphatic endothelial cells in the mammalian leptomeninges. Acta Neuropathol. 2020;139:383-401 pubmed publisher
  112. Helsley R, Varadharajan V, Brown A, Gromovsky A, Schugar R, Ramachandiran I, et al. Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease. elife. 2019;8: pubmed publisher
  113. Zhang F, Parayath N, Ene C, Stephan S, Koehne A, Coon M, et al. Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers. Nat Commun. 2019;10:3974 pubmed publisher
  114. Dangaj D, Bruand M, Grimm A, Ronet C, Barras D, Duttagupta P, et al. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors. Cancer Cell. 2019;35:885-900.e10 pubmed publisher
  115. Sabol R, Bowles A, Côté A, Wise R, O Donnell B, Matossian M, et al. Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumorigenesis of triple-negative breast cancer in orthotopic xenograft and patient-derived xenograft models. Breast Cancer Res. 2019;21:67 pubmed publisher
  116. Binnewies M, Mujal A, Pollack J, Combes A, Hardison E, Barry K, et al. Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity. Cell. 2019;177:556-571.e16 pubmed publisher
  117. Farbehi N, Patrick R, Dorison A, Xaymardan M, Janbandhu V, Wystub Lis K, et al. Single-cell expression profiling reveals dynamic flux of cardiac stromal, vascular and immune cells in health and injury. elife. 2019;8: pubmed publisher
  118. Zhu W, Zhao Z, Chou F, Zuo L, Liu T, Yeh S, et al. Loss of the androgen receptor suppresses intrarenal calcium oxalate crystals deposition via altering macrophage recruitment/M2 polarization with change of the miR-185-5p/CSF-1 signals. Cell Death Dis. 2019;10:275 pubmed publisher
  119. Chakarov S, Lim H, Tan L, Lim S, See P, Lum J, et al. Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches. Science. 2019;363: pubmed publisher
  120. Goody D, Gupta S, Engelmann D, Spitschak A, Marquardt S, Mikkat S, et al. Drug Repositioning Inferred from E2F1-Coregulator Interactions Studies for the Prevention and Treatment of Metastatic Cancers. Theranostics. 2019;9:1490-1509 pubmed publisher
  121. Arora H, Wilcox S, Johnson L, Munro L, Eyford B, Pfeifer C, et al. The ATP-Binding Cassette Gene ABCF1 Functions as an E2 Ubiquitin-Conjugating Enzyme Controlling Macrophage Polarization to Dampen Lethal Septic Shock. Immunity. 2019;50:418-431.e6 pubmed publisher
  122. Zhang J, Li H, Wu Q, Chen Y, Deng Y, Yang Z, et al. Tumoral NOX4 recruits M2 tumor-associated macrophages via ROS/PI3K signaling-dependent various cytokine production to promote NSCLC growth. Redox Biol. 2019;22:101116 pubmed publisher
  123. Kubli S, Bassi C, Roux C, Wakeham A, Göbl C, Zhou W, et al. AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer. Proc Natl Acad Sci U S A. 2019;116:3604-3613 pubmed publisher
  124. Georgouli M, Herraiz C, Crosas Molist E, Fanshawe B, Maiques O, Perdrix A, et al. Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment. Cell. 2019;176:757-774.e23 pubmed publisher
  125. Jordão M, Sankowski R, Brendecke S, Sagar -, Locatelli G, Tai Y, et al. Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation. Science. 2019;363: pubmed publisher
  126. Ma W, Silverman S, Zhao L, Villasmil R, Campos M, Amaral J, et al. Absence of TGFβ signaling in retinal microglia induces retinal degeneration and exacerbates choroidal neovascularization. elife. 2019;8: pubmed publisher
  127. Liu M, O Connor R, Trefely S, Graham K, Snyder N, Beatty G. Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47-mediated 'don't-eat-me' signal. Nat Immunol. 2019;20:265-275 pubmed publisher
  128. Freemerman A, Zhao L, Pingili A, Teng B, Cozzo A, Fuller A, et al. Myeloid Slc2a1-Deficient Murine Model Revealed Macrophage Activation and Metabolic Phenotype Are Fueled by GLUT1. J Immunol. 2019;202:1265-1286 pubmed publisher
  129. Al Mamun A, Yu H, Mirza M, Romana S, McCullough L, Liu F. Myeloid cell IRF4 signaling protects neonatal brains from hypoxic ischemic encephalopathy. Neurochem Int. 2019;127:148-157 pubmed publisher
  130. Kaplanov I, Carmi Y, Kornetsky R, Shemesh A, Shurin G, Shurin M, et al. Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation. Proc Natl Acad Sci U S A. 2019;116:1361-1369 pubmed publisher
  131. Sato Y, Bolzenius J, Eteleeb A, Su X, Maher C, Sehn J, et al. CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade. JCI Insight. 2018;3: pubmed publisher
  132. Zeiner P, Preusse C, Golebiewska A, Zinke J, Iriondo A, Muller A, et al. Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas. Brain Pathol. 2019;29:513-529 pubmed publisher
  133. Cortés Selva D, Elvington A, Ready A, Rajwa B, Pearce E, Randolph G, et al. Schistosoma mansoni Infection-Induced Transcriptional Changes in Hepatic Macrophage Metabolism Correlate With an Athero-Protective Phenotype. Front Immunol. 2018;9:2580 pubmed publisher
  134. Ushio A, Arakaki R, Otsuka K, Yamada A, Tsunematsu T, Kudo Y, et al. CCL22-Producing Resident Macrophages Enhance T Cell Response in Sjögren's Syndrome. Front Immunol. 2018;9:2594 pubmed publisher
  135. Cabron A, El Azzouzi K, Boss M, Arnold P, Schwarz J, Rosas M, et al. Structural and Functional Analyses of the Shedding Protease ADAM17 in HoxB8-Immortalized Macrophages and Dendritic-like Cells. J Immunol. 2018;201:3106-3118 pubmed publisher
  136. Zhou L, Bi C, Gao L, An Y, Chen F, Chen F. Macrophage polarization in human gingival tissue in response to periodontal disease. Oral Dis. 2019;25:265-273 pubmed publisher
  137. Tan B, Shi X, Zhang J, Qin J, Zhang N, Ren H, et al. Inhibition of Rspo-Lgr4 Facilitates Checkpoint Blockade Therapy by Switching Macrophage Polarization. Cancer Res. 2018;78:4929-4942 pubmed publisher
  138. Bezhaeva T, De Vries M, Geelhoed W, van der Veer E, Versteeg S, van Alem C, et al. Relaxin receptor deficiency promotes vascular inflammation and impairs outward remodeling in arteriovenous fistulas. FASEB J. 2018;:fj201800437R pubmed publisher
  139. Kyung D, Sung H, Kim Y, Kim K, Cho S, Choi J, et al. Global transcriptome analysis identifies weight regain-induced activation of adaptive immune responses in white adipose tissue of mice. Int J Obes (Lond). 2018;42:755-764 pubmed publisher
  140. Xi J, Huang Q, Wang L, Ma X, Deng Q, Kumar M, et al. miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy. Oncogene. 2018;37:3151-3165 pubmed publisher
  141. Macdougall C, Wood E, Loschko J, Scagliotti V, Cassidy F, Robinson M, et al. Visceral Adipose Tissue Immune Homeostasis Is Regulated by the Crosstalk between Adipocytes and Dendritic Cell Subsets. Cell Metab. 2018;27:588-601.e4 pubmed publisher
  142. Giurisato E, Xu Q, Lonardi S, Telfer B, Russo I, Pearson A, et al. Myeloid ERK5 deficiency suppresses tumor growth by blocking protumor macrophage polarization via STAT3 inhibition. Proc Natl Acad Sci U S A. 2018;115:E2801-E2810 pubmed publisher
  143. Panduro M, Benoist C, Mathis D. Treg cells limit IFN-? production to control macrophage accrual and phenotype during skeletal muscle regeneration. Proc Natl Acad Sci U S A. 2018;115:E2585-E2593 pubmed publisher
  144. Zhu Y, Zhou J, Feng Y, Chen L, Zhang L, Yang F, et al. Control of Intestinal Inflammation, Colitis-Associated Tumorigenesis, and Macrophage Polarization by Fibrinogen-Like Protein 2. Front Immunol. 2018;9:87 pubmed publisher
  145. Perry C, Muñoz Rojas A, Meeth K, Kellman L, Amezquita R, Thakral D, et al. Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity. J Exp Med. 2018;215:877-893 pubmed publisher
  146. Ireland L, Santos A, Campbell F, Figueiredo C, Hammond D, Ellies L, et al. Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer. Oncogene. 2018;37:2022-2036 pubmed publisher
  147. Meng Y, Zhou W, Jin L, Liu L, Chang K, Mei J, et al. RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization. Cell Death Dis. 2017;8:e3105 pubmed publisher
  148. Giampazolias E, Zunino B, Dhayade S, Bock F, Cloix C, Cao K, et al. Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency. Nat Cell Biol. 2017;19:1116-1129 pubmed publisher
  149. Hannibal T, Schmidt Christensen A, Nilsson J, Fransén Pettersson N, Hansen L, Holmberg D. Deficiency in plasmacytoid dendritic cells and type I interferon signalling prevents diet-induced obesity and insulin resistance in mice. Diabetologia. 2017;60:2033-2041 pubmed publisher
  150. Bosurgi L, Cao Y, Cabeza Cabrerizo M, Tucci A, Hughes L, Kong Y, et al. Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cells. Science. 2017;356:1072-1076 pubmed publisher
  151. Daley D, Mani V, Mohan N, Akkad N, Pandian G, Savadkar S, et al. NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma. J Exp Med. 2017;214:1711-1724 pubmed publisher
  152. A Gonzalez N, Quintana J, Garcia Silva S, Mazariegos M, González de la Aleja A, Nicolás Ávila J, et al. Phagocytosis imprints heterogeneity in tissue-resident macrophages. J Exp Med. 2017;214:1281-1296 pubmed publisher
  153. Daley D, Mani V, Mohan N, Akkad N, Ochi A, Heindel D, et al. Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance. Nat Med. 2017;23:556-567 pubmed publisher
  154. Liu Z, Ravindranathan R, Kalinski P, Guo Z, Bartlett D. Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy. Nat Commun. 2017;8:14754 pubmed publisher
  155. Hui X, Zhang M, Gu P, Li K, Gao Y, Wu D, et al. Adipocyte SIRT1 controls systemic insulin sensitivity by modulating macrophages in adipose tissue. EMBO Rep. 2017;18:645-657 pubmed publisher
  156. Ramos G, van den Berg A, Nunes Silva V, Weirather J, Peters L, Burkard M, et al. Myocardial aging as a T-cell-mediated phenomenon. Proc Natl Acad Sci U S A. 2017;114:E2420-E2429 pubmed publisher
  157. Carmona Fontaine C, Deforet M, Akkari L, Thompson C, Joyce J, Xavier J. Metabolic origins of spatial organization in the tumor microenvironment. Proc Natl Acad Sci U S A. 2017;114:2934-2939 pubmed publisher
  158. Hartwig T, Montinaro A, von Karstedt S, Sevko A, Surinova S, Chakravarthy A, et al. The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2. Mol Cell. 2017;65:730-742.e5 pubmed publisher
  159. Gao S, Li C, Zhu Y, Wang Y, Sui A, Zhong Y, et al. PEDF mediates pathological neovascularization by regulating macrophage recruitment and polarization in the mouse model of oxygen-induced retinopathy. Sci Rep. 2017;7:42846 pubmed publisher
  160. Nicolas N, Michel V, Bhushan S, Wahle E, Hayward S, Ludlow H, et al. Testicular activin and follistatin levels are elevated during the course of experimental autoimmune epididymo-orchitis in mice. Sci Rep. 2017;7:42391 pubmed publisher
  161. Ying W, Wollam J, Ofrecio J, Bandyopadhyay G, El Ouarrat D, Lee Y, et al. Adipose tissue B2 cells promote insulin resistance through leukotriene LTB4/LTB4R1 signaling. J Clin Invest. 2017;127:1019-1030 pubmed publisher
  162. Cuccarese M, Dubach J, Pfirschke C, Engblom C, Garris C, Miller M, et al. Heterogeneity of macrophage infiltration and therapeutic response in lung carcinoma revealed by 3D organ imaging. Nat Commun. 2017;8:14293 pubmed publisher
  163. Zhu Y, Lyapichev K, Lee D, Motti D, Ferraro N, Zhang Y, et al. Macrophage Transcriptional Profile Identifies Lipid Catabolic Pathways That Can Be Therapeutically Targeted after Spinal Cord Injury. J Neurosci. 2017;37:2362-2376 pubmed publisher
  164. Yanagita T, Murata Y, Tanaka D, Motegi S, Arai E, Daniwijaya E, et al. Anti-SIRPα antibodies as a potential new tool for cancer immunotherapy. JCI Insight. 2017;2:e89140 pubmed publisher
  165. Xue N, Zhou Q, Ji M, Jin J, Lai F, Chen J, et al. Chlorogenic acid inhibits glioblastoma growth through repolarizating macrophage from M2 to M1 phenotype. Sci Rep. 2017;7:39011 pubmed publisher
  166. Hellström Erkenstam N, Smith P, Fleiss B, Nair S, Svedin P, Wang W, et al. Temporal Characterization of Microglia/Macrophage Phenotypes in a Mouse Model of Neonatal Hypoxic-Ischemic Brain Injury. Front Cell Neurosci. 2016;10:286 pubmed publisher
  167. Long M, Eddy W, Gong K, Lovelace Macon L, McMahan R, Charron J, et al. MEK1/2 Inhibition Promotes Macrophage Reparative Properties. J Immunol. 2017;198:862-872 pubmed publisher
  168. Wang X, Cao Q, Yu L, Shi H, Xue B, Shi H. Epigenetic regulation of macrophage polarization and inflammation by DNA methylation in obesity. JCI Insight. 2016;1:e87748 pubmed publisher
  169. Tahiri H, Omri S, Yang C, Duhamel F, Samarani S, Ahmad A, et al. Lymphocytic Microparticles Modulate Angiogenic Properties of Macrophages in Laser-induced Choroidal Neovascularization. Sci Rep. 2016;6:37391 pubmed publisher
  170. Hammer A, Yang G, Friedrich J, Kovacs A, Lee D, Grave K, et al. Role of the receptor Mas in macrophage-mediated inflammation in vivo. Proc Natl Acad Sci U S A. 2016;113:14109-14114 pubmed
  171. Jackson I, Zhang Y, Bentzen S, Hu J, Zhang A, Vujaskovic Z. Pathophysiological mechanisms underlying phenotypic differences in pulmonary radioresponse. Sci Rep. 2016;6:36579 pubmed publisher
  172. Barnett F, Rosenfeld M, Wood M, Kiosses W, Usui Y, Marchetti V, et al. Macrophages form functional vascular mimicry channels in vivo. Sci Rep. 2016;6:36659 pubmed publisher
  173. Smirnova T, Bonapace L, MacDonald G, Kondo S, Wyckoff J, Ebersbach H, et al. Serpin E2 promotes breast cancer metastasis by remodeling the tumor matrix and polarizing tumor associated macrophages. Oncotarget. 2016;7:82289-82304 pubmed publisher
  174. Zhou Z, Tang Y, Jin X, Chen C, Lu Y, Liu L, et al. Metformin Inhibits Advanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activation and RAGE/NF?B Pathway Suppression. J Diabetes Res. 2016;2016:4847812 pubmed
  175. Rantakari P, Jäppinen N, Lokka E, Mokkala E, Gerke H, Peuhu E, et al. Fetal liver endothelium regulates the seeding of tissue-resident macrophages. Nature. 2016;538:392-396 pubmed publisher
  176. Pang Y, Dai X, Roller A, Carter K, Paul I, Bhatt A, et al. Early Postnatal Lipopolysaccharide Exposure Leads to Enhanced Neurogenesis and Impaired Communicative Functions in Rats. PLoS ONE. 2016;11:e0164403 pubmed publisher
  177. Arakaki R, Yamasaki T, Kanno T, Shibasaki N, Sakamoto H, Utsunomiya N, et al. CCL2 as a potential therapeutic target for clear cell renal cell carcinoma. Cancer Med. 2016;5:2920-2933 pubmed publisher
  178. Vigeland C, Collins S, Chan Li Y, Hughes A, Oh M, Powell J, et al. Deletion of mTORC1 Activity in CD4+ T Cells Is Associated with Lung Fibrosis and Increased γδ T Cells. PLoS ONE. 2016;11:e0163288 pubmed publisher
  179. Kaneda M, Messer K, Ralainirina N, Li H, Leem C, Gorjestani S, et al. PI3Kγ is a molecular switch that controls immune suppression. Nature. 2016;539:437-442 pubmed publisher
  180. Barin J, Talor M, Schaub J, Diny N, Hou X, Hoyer M, et al. Collaborative Interferon-? and Interleukin-17 Signaling Protects the Oral Mucosa from Staphylococcus aureus. Am J Pathol. 2016;186:2337-52 pubmed publisher
  181. Coppo M, Chinenov Y, Sacta M, Rogatsky I. The transcriptional coregulator GRIP1 controls macrophage polarization and metabolic homeostasis. Nat Commun. 2016;7:12254 pubmed publisher
  182. Rex J, Albrecht U, Ehlting C, Thomas M, Zanger U, Sawodny O, et al. Model-Based Characterization of Inflammatory Gene Expression Patterns of Activated Macrophages. PLoS Comput Biol. 2016;12:e1005018 pubmed publisher
  183. Lesina M, Wörmann S, Morton J, Diakopoulos K, Korneeva O, Wimmer M, et al. RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis. J Clin Invest. 2016;126:2919-32 pubmed publisher
  184. Kojima Y, Volkmer J, McKenna K, Civelek M, Lusis A, Miller C, et al. CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature. 2016;536:86-90 pubmed
  185. Ni T, Liu Y, Peng Y, Li M, Fang Y, Yao M. Substance P induces inflammatory responses involving NF-?B in genetically diabetic mice skin fibroblasts co-cultured with macrophages. Am J Transl Res. 2016;8:2179-88 pubmed
  186. Dai Y, Miao Y, Wu W, Li Y, D Errico F, Su W, et al. Ablation of Liver X receptors ? and ? leads to spontaneous peripheral squamous cell lung cancer in mice. Proc Natl Acad Sci U S A. 2016;113:7614-9 pubmed publisher
  187. Chen P, Roh W, Reuben A, Cooper Z, Spencer C, Prieto P, et al. Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade. Cancer Discov. 2016;6:827-37 pubmed publisher
  188. Casella G, Garzetti L, Gatta A, Finardi A, Maiorino C, Ruffini F, et al. IL4 induces IL6-producing M2 macrophages associated to inhibition of neuroinflammation in vitro and in vivo. J Neuroinflammation. 2016;13:139 pubmed publisher
  189. Wang Y, Hu C, Li J, You X, Gao F. Increased translocation of antigens to endosomes and TLR4 mediated endosomal recruitment of TAP contribute to nicotine augmented cross-presentation. Oncotarget. 2016;7:38451-38466 pubmed publisher
  190. Shiraishi M, Shintani Y, Shintani Y, Ishida H, Saba R, Yamaguchi A, et al. Alternatively activated macrophages determine repair of the infarcted adult murine heart. J Clin Invest. 2016;126:2151-66 pubmed publisher
  191. Yin S, Jian F, Chen Y, Chien S, Hsieh M, Hsiao P, et al. Induction of IL-25 secretion from tumour-associated fibroblasts suppresses mammary tumour metastasis. Nat Commun. 2016;7:11311 pubmed publisher
  192. Basrai H, Christie K, Turbic A, Bye N, Turnley A. Suppressor of Cytokine Signaling-2 (SOCS2) Regulates the Microglial Response and Improves Functional Outcome after Traumatic Brain Injury in Mice. PLoS ONE. 2016;11:e0153418 pubmed publisher
  193. Wezel A, De Vries M, Maassen J, Kip P, Peters E, Karper J, et al. Deficiency of the TLR4 analogue RP105 aggravates vein graft disease by inducing a pro-inflammatory response. Sci Rep. 2016;6:24248 pubmed publisher
  194. Tan S, Krasnow M. Developmental origin of lung macrophage diversity. Development. 2016;143:1318-27 pubmed publisher
  195. Gabunia K, Ellison S, Kelemen S, Kako F, Cornwell W, Rogers T, et al. IL-19 Halts Progression of Atherosclerotic Plaque, Polarizes, and Increases Cholesterol Uptake and Efflux in Macrophages. Am J Pathol. 2016;186:1361-74 pubmed publisher
  196. Seifert L, Werba G, Tiwari S, Giao Ly N, Nguy S, Alothman S, et al. Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice. Gastroenterology. 2016;150:1659-1672.e5 pubmed publisher
  197. Tsaousi A, Hayes E, Di Gregoli K, Bond A, Bevan L, Thomas A, et al. Plaque Size Is Decreased but M1 Macrophage Polarization and Rupture Related Metalloproteinase Expression Are Maintained after Deleting T-Bet in ApoE Null Mice. PLoS ONE. 2016;11:e0148873 pubmed publisher
  198. Nomura M, Liu J, Rovira I, Gonzalez Hurtado E, Lee J, Wolfgang M, et al. Fatty acid oxidation in macrophage polarization. Nat Immunol. 2016;17:216-7 pubmed publisher
  199. Xiao J, Shao L, Shen J, Jiang W, Feng Y, Zheng P, et al. Effects of ketanserin on experimental colitis in mice and macrophage function. Int J Mol Med. 2016;37:659-68 pubmed publisher
  200. Ying W, Tseng A, Chang R, Wang H, Lin Y, Kanameni S, et al. miR-150 regulates obesity-associated insulin resistance by controlling B cell functions. Sci Rep. 2016;6:20176 pubmed publisher
  201. Singla D, Singla R, Wang J. BMP-7 Treatment Increases M2 Macrophage Differentiation and Reduces Inflammation and Plaque Formation in Apo E-/- Mice. PLoS ONE. 2016;11:e0147897 pubmed publisher
  202. McCubbrey A, Nelson J, Stolberg V, Blakely P, McCloskey L, Janssen W, et al. MicroRNA-34a Negatively Regulates Efferocytosis by Tissue Macrophages in Part via SIRT1. J Immunol. 2016;196:1366-75 pubmed publisher
  203. Pylayeva Gupta Y, Das S, Handler J, Hajdu C, Coffre M, Koralov S, et al. IL35-Producing B Cells Promote the Development of Pancreatic Neoplasia. Cancer Discov. 2016;6:247-55 pubmed publisher
  204. Mareninova O, Sendler M, Malla S, Yakubov I, French S, Tokhtaeva E, et al. Lysosome associated membrane proteins maintain pancreatic acinar cell homeostasis: LAMP-2 deficient mice develop pancreatitis. Cell Mol Gastroenterol Hepatol. 2015;1:678-694 pubmed
  205. Scholz A, Harter P, Cremer S, Yalcin B, Gurnik S, Yamaji M, et al. Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma. EMBO Mol Med. 2016;8:39-57 pubmed publisher
  206. Jiao H, Natoli R, Valter K, Provis J, Rutar M. Spatiotemporal Cadence of Macrophage Polarisation in a Model of Light-Induced Retinal Degeneration. PLoS ONE. 2015;10:e0143952 pubmed publisher
  207. Onodera T, Fukuhara A, Jang M, Shin J, Aoi K, Kikuta J, et al. Adipose tissue macrophages induce PPARγ-high FOXP3(+) regulatory T cells. Sci Rep. 2015;5:16801 pubmed publisher
  208. Su S, Zhao Q, He C, Huang D, Liu J, Chen F, et al. miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program. Nat Commun. 2015;6:8523 pubmed publisher
  209. Peluffo H, Solari Saquieres P, Negro Demontel M, Francos Quijorna I, Navarro X, Lopez Vales R, et al. CD300f immunoreceptor contributes to peripheral nerve regeneration by the modulation of macrophage inflammatory phenotype. J Neuroinflammation. 2015;12:145 pubmed publisher
  210. Eichin D, Laurila J, Jalkanen S, Salmi M. CD73 Activity is Dispensable for the Polarization of M2 Macrophages. PLoS ONE. 2015;10:e0134721 pubmed publisher
  211. Wang J, Ma L, Tang X, Zhang X, Qiao Y, Shi Y, et al. Doxorubicin induces apoptosis by targeting Madcam1 and AKT and inhibiting protein translation initiation in hepatocellular carcinoma cells. Oncotarget. 2015;6:24075-91 pubmed
  212. Napolitano A, Pellegrini L, Dey A, Larson D, Tanji M, Flores E, et al. Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma. Oncogene. 2016;35:1996-2002 pubmed publisher
  213. Jin X, Yao T, Zhou Z, Zhu J, Zhang S, Hu W, et al. Advanced Glycation End Products Enhance Macrophages Polarization into M1 Phenotype through Activating RAGE/NF-κB Pathway. Biomed Res Int. 2015;2015:732450 pubmed publisher
  214. Keswani R, Yoon G, Sud S, Stringer K, Rosania G. A far-red fluorescent probe for flow cytometry and image-based functional studies of xenobiotic sequestering macrophages. Cytometry A. 2015;87:855-67 pubmed publisher
  215. Yang X, Zhang Y, Hosaka K, Andersson P, Wang J, Tholander F, et al. VEGF-B promotes cancer metastasis through a VEGF-A-independent mechanism and serves as a marker of poor prognosis for cancer patients. Proc Natl Acad Sci U S A. 2015;112:E2900-9 pubmed publisher
  216. Xue J, Sharma V, Hsieh M, Chawla A, Murali R, Pandol S, et al. Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis. Nat Commun. 2015;6:7158 pubmed publisher
  217. Sun L, Zhou H, Zhu Z, Yan Q, Wang L, Liang Q, et al. Ex vivo and in vitro effect of serum amyloid a in the induction of macrophage M2 markers and efferocytosis of apoptotic neutrophils. J Immunol. 2015;194:4891-900 pubmed publisher
  218. Choi E, Park H, Sul O, Rajasekaran M, Yu R, Choi H. Carbon monoxide reverses adipose tissue inflammation and insulin resistance upon loss of ovarian function. Am J Physiol Endocrinol Metab. 2015;308:E621-30 pubmed publisher
  219. Evans E, Jonason A, Bussler H, Torno S, Veeraraghavan J, Reilly C, et al. Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies. Cancer Immunol Res. 2015;3:689-701 pubmed publisher
  220. Teixeira L, Moreira J, Melo J, Bezerra F, Marques R, Ferreirinha P, et al. Immune response in the adipose tissue of lean mice infected with the protozoan parasite Neospora caninum. Immunology. 2015;145:242-57 pubmed publisher
  221. Kumar M, Csaba Z, Peineau S, Srivastava R, Rasika S, Mani S, et al. Endogenous cerebellar neurogenesis in adult mice with progressive ataxia. Ann Clin Transl Neurol. 2014;1:968-81 pubmed publisher
  222. Reiner A, Heldt S, Presley C, Guley N, Elberger A, Deng Y, et al. Motor, visual and emotional deficits in mice after closed-head mild traumatic brain injury are alleviated by the novel CB2 inverse agonist SMM-189. Int J Mol Sci. 2014;16:758-87 pubmed publisher
  223. Zemany L, Bhanot S, Peroni O, Murray S, Moraes Vieira P, Castoldi A, et al. Transthyretin Antisense Oligonucleotides Lower Circulating RBP4 Levels and Improve Insulin Sensitivity in Obese Mice. Diabetes. 2015;64:1603-14 pubmed publisher
  224. Hayashi N, Kataoka H, Yano S, Tanaka M, Moriwaki K, Akashi H, et al. A novel photodynamic therapy targeting cancer cells and tumor-associated macrophages. Mol Cancer Ther. 2015;14:452-60 pubmed publisher
  225. Almolda B, de Labra C, Barrera I, Gruart A, Delgado Garcia J, Villacampa N, et al. Alterations in microglial phenotype and hippocampal neuronal function in transgenic mice with astrocyte-targeted production of interleukin-10. Brain Behav Immun. 2015;45:80-97 pubmed publisher
  226. Mehta P, Nuotio Antar A, Smith C. γδ T cells promote inflammation and insulin resistance during high fat diet-induced obesity in mice. J Leukoc Biol. 2015;97:121-34 pubmed publisher
  227. Okuneva O, Körber I, Li Z, Tian L, Joensuu T, Kopra O, et al. Abnormal microglial activation in the Cstb(-/-) mouse, a model for progressive myoclonus epilepsy, EPM1. Glia. 2015;63:400-11 pubmed publisher
  228. Zhan X, Jia L, Niu Y, Qi H, Chen X, Zhang Q, et al. Targeted depletion of tumour-associated macrophages by an alendronate-glucomannan conjugate for cancer immunotherapy. Biomaterials. 2014;35:10046-57 pubmed publisher
  229. Rauen J, Kreer C, Paillard A, van Duikeren S, Benckhuijsen W, Camps M, et al. Enhanced cross-presentation and improved CD8+ T cell responses after mannosylation of synthetic long peptides in mice. PLoS ONE. 2014;9:e103755 pubmed publisher
  230. Zhu Y, Knolhoff B, Meyer M, Nywening T, West B, Luo J, et al. CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res. 2014;74:5057-69 pubmed publisher
  231. Moreno M, Bannerman P, Ma J, Guo F, Miers L, Soulika A, et al. Conditional ablation of astroglial CCL2 suppresses CNS accumulation of M1 macrophages and preserves axons in mice with MOG peptide EAE. J Neurosci. 2014;34:8175-85 pubmed publisher
  232. Johnston Cox H, Eisenstein A, Koupenova M, Carroll S, Ravid K. The macrophage A2B adenosine receptor regulates tissue insulin sensitivity. PLoS ONE. 2014;9:e98775 pubmed publisher
  233. Eskilsson A, Tachikawa M, Hosoya K, Blomqvist A. Distribution of microsomal prostaglandin E synthase-1 in the mouse brain. J Comp Neurol. 2014;522:3229-44 pubmed publisher
  234. Anders C, Ashton N, Ranjzad P, Dilworth M, Woolf A. Ex vivo modeling of chemical synergy in prenatal kidney cystogenesis. PLoS ONE. 2013;8:e57797 pubmed publisher
  235. Tan J, Chan S, Wallace E, Lim R. Human amnion epithelial cells mediate lung repair by directly modulating macrophage recruitment and polarization. Cell Transplant. 2014;23:319-28 pubmed publisher
  236. Colton C. Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol. 2009;4:399-418 pubmed publisher